<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73542</article-id><article-id pub-id-type="doi">10.7554/eLife.73542</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer’s disease synapse model</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-252008"><name><surname>Hori</surname><given-names>Tetsuya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0823-3306</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-165297"><name><surname>Eguchi</surname><given-names>Kohgaku</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6170-2546</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101204"><name><surname>Wang</surname><given-names>Han-Ying</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3021-7134</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153989"><name><surname>Miyasaka</surname><given-names>Tomohiro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-78282"><name><surname>Guillaud</surname><given-names>Laurent</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9688-0991</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252673"><name><surname>Taoufiq</surname><given-names>Zacharie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274498"><name><surname>Mahapatra</surname><given-names>Satyajit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-92713"><name><surname>Yamada</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86520"><name><surname>Takei</surname><given-names>Kohji</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-78676"><name><surname>Takahashi</surname><given-names>Tomoyuki</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8771-7666</contrib-id><email>ttakahas@oist.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qg15b79</institution-id><institution>Cellular and Molecular Synaptic Function Unit, Okinawa Institute of Science and Technology - Graduate University</institution></institution-wrap><addr-line><named-content content-type="city">Okinawa</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01fxdkm29</institution-id><institution>Faculty of Life and Medical Sciences, Doshisha University</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03gnh5541</institution-id><institution>Institute of Science and Technology Austria (IST Austria)</institution></institution-wrap><addr-line><named-content content-type="city">Klosterneuburg</named-content></addr-line><country>Austria</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qg15b79</institution-id><institution>Molecular Neuroscience Unit, Okinawa Institute of Science and Technology Graduate University</institution></institution-wrap><addr-line><named-content content-type="city">Okinawa</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pc6pc55</institution-id><institution>Department of Neuroscience, Graduate school of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University</institution></institution-wrap><addr-line><named-content content-type="city">Okayama</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a7f6w43</institution-id><institution>Max Planck Institute of Experimental Medicine</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>26</day><month>04</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e73542</elocation-id><history><date date-type="received" iso-8601-date="2021-09-02"><day>02</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-04-20"><day>20</day><month>04</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-09-14"><day>14</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.13.460074"/></event></pub-history><permissions><copyright-statement>© 2022, Hori et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hori et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73542-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-73542-figures-v2.pdf"/><abstract><p>Elevation of soluble wild-type (WT) tau occurs in synaptic compartments in Alzheimer’s disease. We addressed whether tau elevation affects synaptic transmission at the calyx of Held in slices from mice brainstem. Whole-cell loading of WT human tau (h-tau) in presynaptic terminals at 10–20 µM caused microtubule (MT) assembly and activity-dependent rundown of excitatory neurotransmission. Capacitance measurements revealed that the primary target of WT h-tau is vesicle endocytosis. Blocking MT assembly using nocodazole prevented tau-induced impairments of endocytosis and neurotransmission. Immunofluorescence imaging analyses revealed that MT assembly by WT h-tau loading was associated with an increased MT-bound fraction of the endocytic protein dynamin. A synthetic dodecapeptide corresponding to dynamin 1-pleckstrin-homology domain inhibited MT-dynamin interaction and rescued tau-induced impairments of endocytosis and neurotransmission. We conclude that elevation of presynaptic WT tau induces de novo assembly of MTs, thereby sequestering free dynamins. As a result, endocytosis and subsequent vesicle replenishment are impaired, causing activity-dependent rundown of neurotransmission.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tau</kwd><kwd>excitatory synaptic transmission</kwd><kwd>calyx of Held presynaptic terminal</kwd><kwd>microtubule</kwd><kwd>dynamin</kwd><kwd>endocytosis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004199</institution-id><institution>Okinawa Institute of Science and Technology Graduate University</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Takahashi</surname><given-names>Tomoyuki</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Core Research for Evolutional Science and Technology</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Takahashi</surname><given-names>Tomoyuki</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Grant-in-Aid for Scientific Research on Innovative Areas</award-id><principal-award-recipient><name><surname>Miyasaka</surname><given-names>Tomohiro</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>26117004</award-id><principal-award-recipient><name><surname>Miyasaka</surname><given-names>Tomohiro</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Wild-type human recombinant tau protein infused in presynaptic terminals newly assembled microtubules, which sequestered cytosolic dynamins, thereby blocking synaptic vesicle endocytosis and causing activity-dependent rundown of excitatory synaptic transmission in a slice model of mouse brainstem.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The microtubule (MT)-binding protein tau assembles and stabilizes MTs (<xref ref-type="bibr" rid="bib5">Brunden et al., 2009</xref>; <xref ref-type="bibr" rid="bib32">Lee et al., 2011</xref>) mainly in axonal compartments (<xref ref-type="bibr" rid="bib4">Binder et al., 1985</xref>; <xref ref-type="bibr" rid="bib30">Kubo et al., 2019</xref>). Phosphorylation of tau proteins reduces their binding affinity (<xref ref-type="bibr" rid="bib3">Biernat et al., 1993</xref>; <xref ref-type="bibr" rid="bib7">Drechsel et al., 1992</xref>), thereby shifting the equilibrium from MT-bound form to soluble free form (<xref ref-type="bibr" rid="bib1">Ballatore et al., 2007</xref>). Soluble tau proteins also exist in dynamic equilibrium between phosphorylated and dephosphorylated forms (<xref ref-type="bibr" rid="bib56">Spillantini and Goedert, 2013</xref>) as well as between soluble and aggregated forms. When the cytosolic tau concentration is elevated, monomeric tau undergoes oligomerization and eventually precipitates into neurofibrillary tangles (NFT) (<xref ref-type="bibr" rid="bib15">Greenberg and Davies, 1990</xref>; <xref ref-type="bibr" rid="bib16">Grundke-Iqbal et al., 1986</xref>; <xref ref-type="bibr" rid="bib73">Yoshida and Ihara, 1993</xref>), which is a hallmark of tauopathies, including Alzheimer’s disease (AD), frontotemporal dementia with Parkinsonism-17 (FTDP-17), and progressive supranuclear palsy (<xref ref-type="bibr" rid="bib32">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib1">Ballatore et al., 2007</xref>; <xref ref-type="bibr" rid="bib56">Spillantini and Goedert, 2013</xref>). Although the NFT density can correlate with the degree of AD progression (<xref ref-type="bibr" rid="bib32">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib1">Ballatore et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Morris et al., 2011</xref>), soluble tau protein levels are more closely linked to disease progression and cognitive decline (<xref ref-type="bibr" rid="bib14">Götz et al., 2008</xref>; <xref ref-type="bibr" rid="bib29">Koss et al., 2016</xref>).</p><p>Genetic ablation of tau shows little abnormal phenotype (<xref ref-type="bibr" rid="bib20">Harada et al., 1994</xref>; <xref ref-type="bibr" rid="bib66">Vossel et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">Yuan et al., 2008</xref>), presumably due to compensation by other MT-associated proteins (<xref ref-type="bibr" rid="bib20">Harada et al., 1994</xref>). Instead, tau ablation can prevent amyloid β-induced impairments of mitochondrial transport (<xref ref-type="bibr" rid="bib66">Vossel et al., 2010</xref>) or memory defects (<xref ref-type="bibr" rid="bib25">Ittner et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Roberson et al., 2007</xref>). Thus, loss of tau function due to its dissociation from MTs is unlikely to be an important cause of neuronal dysfunction in AD (<xref ref-type="bibr" rid="bib56">Spillantini and Goedert, 2013</xref>; <xref ref-type="bibr" rid="bib38">Morris et al., 2011</xref>).</p><p>In postmortem brains of both AD patients and intact humans, tau is present in synaptosomes (<xref ref-type="bibr" rid="bib11">Fein et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Tai et al., 2012</xref>). In a transgenic mice AD model, soluble tau is accumulated in the hippocampal nerve terminal zone (<xref ref-type="bibr" rid="bib6">de Calignon et al., 2012</xref>; <xref ref-type="bibr" rid="bib34">Liu et al., 2012</xref>). Both in in vivo and in culture models of tauopathy, tau is released from axon terminals upon KCl stimulation in a Ca<sup>2+</sup>-dependent manner, like neurotransmitters (<xref ref-type="bibr" rid="bib42">Pooler et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Yamada et al., 2014</xref>). Tau oligomers produced by released tau triggers endogenous tau seeding in neighboring neurons, thereby causing trans-synaptic propagations (<xref ref-type="bibr" rid="bib6">de Calignon et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Guo and Lee, 2011</xref>).</p><p>FTDP tauopathy model mice that overexpressed with mutant tau are widely used to examine tau toxicities on synaptic plasticity (<xref ref-type="bibr" rid="bib41">Polydoro et al., 2014</xref>; <xref ref-type="bibr" rid="bib59">Sydow et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">Yoshiyama et al., 2007</xref>), memory formation (<xref ref-type="bibr" rid="bib59">Sydow et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Santacruz et al., 2005</xref>), as well as on synaptic vesicle (SV) transport (<xref ref-type="bibr" rid="bib37">McInnes et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Zhou et al., 2017</xref>). In contrast to FTDP, which is a rare familial disease associated with tau mutation, AD is a widespread sporadic disease unassociated with tau mutation, but the expression level of WT tau being crucial. As AD models, the effects of WT tau overexpression have been examined in culture cells (<xref ref-type="bibr" rid="bib9">Ebneth et al., 1998</xref>; <xref ref-type="bibr" rid="bib50">Shahpasand et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Stamer et al., 2002</xref>; <xref ref-type="bibr" rid="bib65">Thies and Mandelkow, 2007</xref>) or in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib39">Mudher et al., 2004</xref>), where impaired axonal transports associated with increased MT density were found. These observations suggest that WT tau can be detrimental when its levels are elevated (<xref ref-type="bibr" rid="bib57">Stamer et al., 2002</xref>; <xref ref-type="bibr" rid="bib65">Thies and Mandelkow, 2007</xref>). However, unlike FTDP tau mutant, it is unknown whether elevated soluble WT tau can affect mammalian central synaptic transmission.</p><p>We addressed this question using the giant nerve terminal calyx of Held visualized in slices from mice brainstem, where axonal MTs extended into the depth of terminals (<xref ref-type="bibr" rid="bib40">Piriya Ananda Babu et al., 2020</xref>). In this presynaptic terminal, we loaded recombinant WT h-tau from a whole-cell patch pipette at fixed concentrations to model the elevation of WT tau associated with AD and found that WT h-tau newly assembled MTs and strongly impaired synaptic transmission. Capacitance measurements indicated that the primary target of WT h-tau is vesicle endocytosis. Immunocytochemical image analysis after cell permeabilization revealed an increase in the MT-bound fraction of the endocytic GTPase dynamin in WT h-tau-loaded terminals. Since the endocytic key protein dynamin is an MT-binding protein (<xref ref-type="bibr" rid="bib52">Shpetner and Vallee, 1989</xref>), dynamin is likely sequestered by newly assembled MTs. Out of screening, we found that a synthetic dodecapeptide corresponding to amino acids 560–571 of dynamin 1 inhibited MT-dynamin interaction. When we co-loaded this peptide ‘PHDP5’ with WT h-tau, its toxicities on vesicle endocytosis as well as on synaptic transmission were rescued. Thus, we propose a novel synaptic dysfunction mechanism underlying AD, in which WT tau-induced over-assembly of MTs depletes dynamins, thereby impairing vesicle endocytosis and synaptic transmission.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Intra-terminal loading of WT h-tau impairs excitatory synaptic transmission</title><p>To address whether elevation of soluble h-tau in presynaptic terminals can affect synaptic transmission, we purified WT recombinant h-tau (0N4R) and its deletion mutant (del-MTBD) lacking the MT-binding site (<sup>244</sup>Gln–<sup>367</sup>Gly) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), obtained using an <italic>Escherichia coli</italic> expression system (<xref ref-type="bibr" rid="bib69">Xie et al., 2014</xref>). These recombinant h-tau proteins are highly soluble at room temperature (RT) without any sign of granulation (<xref ref-type="bibr" rid="bib36">Maeda et al., 2007</xref>). In simultaneous pre- and postsynaptic recording at the calyx of Held in mouse brainstem slices, we recorded EPSCs evoked at 1 Hz by presynaptic action potentials (<xref ref-type="fig" rid="fig1">Figure 1</xref>). After confirming stable EPSC amplitude for 10 min, we injected a large volume of internal solution containing WT h-tau (20 µM) from an installed fine tube to a presynaptic whole-cell pipette to replace most of pipette solution and allow h-tau to diffuse into a presynaptic terminal (illustration in <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib23">Hori et al., 1999</xref>; <xref ref-type="bibr" rid="bib61">Takahashi et al., 2012</xref>). After loading h-tau (20 µM), the amplitude of glutamatergic EPSCs gradually declined and reached 23% ± 9% in 30 min (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, p &lt; 0.01, paired t-test, n = 6 synapses in 6 slices). WT h-tau loaded at a lower concentration (10 µM) caused a slower EPSC rundown to 65% ± 5% in 30 min (p &lt; 0.01, n = 5 synapses in 5 slices). Del-MTBD (20 µM), lacking tubulin polymerization capability (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), likewise loaded had no effect on EPSC amplitude (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Since h-tau concentrations in presynaptic terminals are equilibrated with those in a presynaptic whole-cell pipette with a much greater volume than terminals (<xref ref-type="bibr" rid="bib43">Pusch and Neher, 1988</xref>), these results suggest that WT h-tau &gt;10 µM can significantly impair excitatory synaptic transmission.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Wild-type (WT) human tau (h-tau) loaded in presynaptic terminals inhibited excitatory synaptic transmission.</title><p>(<bold>A</bold>) In simultaneous pre- and postsynaptic whole-cell recordings, intra-terminal infusion of WT h-tau at 10 µM (blue filled circles) or 20 µM (black filled circles), from a tube in a presynaptic patch pipette (top illustration), caused a concentration-dependent rundown of EPSCs evoked by presynaptic action potentials at 1 Hz. In the time plots, EPSC amplitudes averaged from 60 events are sampled for data points and normalized to the mean amplitude of baseline EPSCs before h-tau infusion. Sample records of EPSCs 5 min before (i) and 30 min after (ii) tau infusion are superimposed and shown on the left panels. The EPSC amplitude remaining 30 min after infusion was 23% ± 9% and 65% ± 5%, respectively, for 10 and 20 µM h-tau (means and SEMs, 6 synapses from 6 slices, p &lt; 0.01 in paired t-test between before and after h-tau infusion). Infusion of microtubule (MT)-binding site-deleted h-tau mutant (del-MTBD, 20 µM, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) had no effect on the EPSC amplitude (open circles, sample EPSC traces shown on the left bottom panel). (<bold>B</bold>) The amplitude of EPSCs evoked at 0.1 Hz remained unchanged after h-tau infusion (85% ± 12%, 5 synapses from 5 slices, p = 0.22 in paired t-test). Sample records of EPSCs before (<bold>i</bold>) and 30 min after (ii) h-tau infusion at 0.1 Hz are superimposed on the left panel. (<bold>C</bold>) Taxol (1 µM) caused activity-dependent rundown of EPSC amplitude to 41.4% ± 12% at 1 Hz (p &lt; 0.01, 5 synapses from 5 slices), but remained unchanged when stimulated at 0.1 Hz (105% ± 3.0%, open circles, 4 synapses from 4 slices). Sample records of EPSCS at 0.1 and 1 Hz are superimposed on the left panels.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Wild-type (WT) h-tau loaded in presynaptic terminals inhibited excitatory synaptic transmission.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Tubulin polymerization assay for purified 0N4R wild-type (WT) human tau (h-tau) and microtubule (MT)-binding region-deleted mutant.</title><p>(<bold>A</bold>) <italic>Left panel</italic>, schematic drawings of WT 0N4R h-tau (<bold>a</bold>) and h-tau deletion mutant lacking the MT-binding region (del-MTBD) (<bold>b</bold>). <italic>Right panel</italic>, purified recombinant WT 0N4R h-tau (<bold>a</bold>) and del-MTBD (<bold>b</bold>) in SDS-PAGE with molecular markers (M) on the left lane. (<bold>B</bold>) In vitro tubulin polymerization assay, showing MT assembly by WT h-tau (10 µM, open circles) or taxol (1 µM, filled triangles), but not by del-MTBD (10 µM, open squares) or tubulin alone (filled circles). Data points and bars represent means and SEMs (n = 3).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Raw SDS-PAGE gel data from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title></caption><media mime-subtype="pptx" mimetype="application" xlink:href="elife-73542-fig1-figsupp1-data1-v2.pptx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Data from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig1-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig1-figsupp1-v2.tif"/></fig></fig-group><p>The inhibitory effect of WT h-tau on EPSCs was apparently frequency-dependent. When evoked at 0.1 Hz, WT h-tau (20 µM) caused only a minor reduction of EPSC amplitude (to 85% ± 12%, 30 min after loading, p = 0.21, n = 5; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). Since taxol shares a common binding site of MTs with tau (<xref ref-type="bibr" rid="bib26">Kar et al., 2003</xref>) and assembles tubulins into MTs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), we tested the effect of taxol (1 µM) on EPSCs (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Like h-tau, taxol caused a significant rundown of EPSCs evoked at 1 Hz (to 41 ± 12 at 30 min, n = 5, p &lt; 0.05), but not those evoked at 0.1 Hz (104% ± 3.0%, n = 4, p = 0.60). These results together suggest that MTs newly assembled in presynaptic terminals by WT h-tau or taxol cause activity-dependent rundown of excitatory synaptic transmission.</p></sec><sec id="s2-2"><title>WT h-tau primarily inhibits SV endocytosis and secondarily exocytosis</title><p>To determine the primary target of h-tau causing synaptic dysfunction, we performed membrane capacitance measurements at the calyx of Held (<xref ref-type="bibr" rid="bib10">Eguchi et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Sun and Wu, 2001</xref>; <xref ref-type="bibr" rid="bib67">Wang et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Yamashita et al., 2005</xref>). Since stray capacitance of perfusion pipettes prevents capacitance measurements, we backfilled h-tau into a conventional patch pipette after preloading normal internal solution only at its tip to secure GΩ seal formation. This caused substantial and variable delays of the intra-terminal diffusion, so no clear effect could be seen more than 10 min after whole-cell patch membrane was ruptured. Twenty minutes after whole-cell patch loading of WT h-tau (20 µM), endocytic capacitance showed a significant slowing (<xref ref-type="fig" rid="fig2">Figure 2</xref>), whereas exocytic capacitance magnitude (ΔC<sub>m</sub>) or charge of Ca<sup>2+</sup> currents (Q<sub>Ca</sub>) induced by a depolarizing pulse was not different from controls without h-tau loading. Thirty minutes after loading h-tau, the endocytic capacitance change became further slowed (p &lt; 0.01), and exocytic ΔC<sub>m</sub> eventually showed a significant reduction (p &lt; 0.05, n = 5) without a change in Q<sub>Ca</sub>. These results suggest that the primary target of h-tau toxicity is SV endocytosis. Endocytic block inhibits recycling replenishment of SVs via recycling, thereby reducing the exocytic release of neurotransmitter as a secondary effect.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Inhibition of synaptic vesicle (SV) endocytosis is the primary effect of wild-type (WT) human tau (h-tau) loading.</title><p>(<bold>A</bold>) Exo-endocytic membrane capacitance changes in presynaptic terminals without (Control) or after direct loading of WT h-tau (20 µM; Tau). WT h-tau was directly loaded by diffusion into a terminal from a whole-cell patch pipette (illustration). Capacitance traces were sampled from (<bold>i</bold>) 10, (ii) 20, and (iii) 30 min after patch membrane rupture (superimposed). <italic>Left panel</italic>, non-loading control. <italic>Right panel</italic>, WT h-tau-loaded terminal. Capacitance changes were evoked every 2 min by Ca<sup>2+</sup> currents induced by a 20 ms depolarizing pulse (not shown). (<bold>B</bold>) Time plots of endocytic rate (left panel), exocytic magnitude (middle panel), and presynaptic Ca<sup>2+</sup> current charge (right panel). Data points represent averaged values from five events from 4 min before and 4 min after the time points. In calyceal terminals, 20 min after patch membrane rupture with a pipette containing WT h-tau (filled circles; Tau), endocytic rate was significantly prolonged (*p &lt; 0.05 compared to controls, open circles, repeated-measures two-way ANOVA with post hoc Scheffe test, n = 5 from 5 slices), whereas exocytic magnitude remained similar to controls (p = 0.45). Thirty minutes after rupture, endocytic rate was further prolonged (**p &lt; 0.01) and exocytic magnitude became significantly less than controls (*p &lt; 0.05). Ca<sup>2+</sup> current charge (Q<sub>Ca</sub>) remained unchanged throughout recording.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Inhibition of synaptic vesicle (SV) endocytosis is the primary effect of wild-type (WT) human tau (h-tau) loading.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig2-v2.tif"/></fig></sec><sec id="s2-3"><title>Inhibition of SV endocytosis and synaptic transmission by WT h-tau requires de novo MT assembly</title><p>Since new MT assembly might take place after h-tau loading (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), we tested whether the tubulin polymerization blocker nocodazole might reverse the toxic effects of h-tau on SV endocytosis and synaptic transmission. In tubulin polymerization assays, nocodazole inhibited h-tau-dependent MT assembly in a concentration-dependent manner, with a maximal inhibition reached at 20 µM (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In presynaptic capacitance measurements, nocodazole (20 µM) co-loaded with h-tau (20 µM) fully prevented the h-tau toxicities on endocytosis (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) and synaptic transmission (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Nocodazole alone (20 µM) had no effect on exo-endocytosis (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) or EPSC amplitude (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). It is highly likely that WT h-tau loaded in calyceal terminals newly assembled MTs, thereby impairing SV endocytosis and synaptic transmission.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The microtubule (MT) assembly blocker nocodazole prevented tau-induced block of synaptic vesicle (SV) endocytosis and EPSC rundown.</title><p>(<bold>A</bold>) Concentration-dependent inhibitory effects of nocodazole on MT assembly in tubulin polymerization assay. MT assembly by 0N4R human tau (h-tau) (20 µM) in the absence (pink symbols and a fitting line) or presence of nocodazole at 1 µM (blue), 10 µM (red), 20 µM (purple), and 50 µM (orange). Data points and error bars in all graphs represent means and SEMs (n = 3). (<bold>B</bold>) Nocodazole prevented h-tau-induced block of SV endocytosis. Presynaptic membrane capacitance changes (superimposed traces) 25 min after loading h-tau alone (20 µM, red trace), h-tau and nocodazole (20 µM, blue), nocodazole alone (20 µM, green), and controls with no loading (black). Bar graphs indicate endocytic rates in non-loading controls (Ctr, black, 6 terminals from 6 slices), h-tau-loaded terminals (Tau, red, 8 terminals from 8 slices), co-loading of nocodazole with h-tau (N + T, blue, 7 terminals from 7 slices), and nocodazole alone (Noc, green, 8 terminals from 8 slices). Nocodazole co-loading fully prevented endocytic block by h-tau (**p &lt; 0.01, between Tau and N-T) to control level (one-way ANOVA with Scheffe post hoc test). (<bold>C</bold>) Nocodazole prevented EPSC rundown caused by wild-type (WT) h-tau. Nocodazole (20 µM) co-loaded with WT h-tau (20 µM) prevented EPSC rundown (filled circles, 4 synapses from 4 slices, **p &lt; 0.01, unpaired t-test). Data of WT h-tau effect on EPSCs (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) is shown as a red dashed line for comparison. Nocodazole alone (20 µM) had no effect on EPSC amplitude throughout (open circles, 4 synapses from 4 slices).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>The microtubule (MT) assembly blocker nocodazole prevented tau-induced block of synaptic vesicle (SV) endocytosis and EPSC rundown.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig3-v2.tif"/></fig></sec><sec id="s2-4"><title>WT h-tau assembles MTs and sequesters dynamins in calyceal terminals</title><p>The monomeric GTPases dynamins 1 and 3 play critical roles in the endocytic fission of SVs (<xref ref-type="bibr" rid="bib22">Hinshaw and Schmid, 1995</xref>; <xref ref-type="bibr" rid="bib44">Raimondi et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Takei et al., 1995</xref>). Since dynamin is originally discovered as an MT-binding protein (<xref ref-type="bibr" rid="bib52">Shpetner and Vallee, 1989</xref>), we hypothesized that newly assembled MTs might trap free dynamins in cytosol. If this is the case, MT-bound form of dynamin would be increased. To test this hypothesis, we performed immunofluorescence microscopy and image analysis to quantify MTs and dynamin. After whole-cell infusion of h-tau into calyceal terminals, slices were chemically fixed and permeabilized to allow cytosolic-free molecules such as tubulin monomers to be washed out of the terminal, thereby enhancing the signals from large structures such as MTs or MT-bound molecules. Fluorescent h-tau antibody identified calyceal terminals loaded with WT h-tau (20 µM, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Double staining with mouse β3-tubulin antibody revealed a 2.1-fold increase in MT signals in h-tau-loaded terminals, compared with those without h-tau loading (p = 0.01, n = 5, two-tailed unpaired t-test with Welch’s correction, <xref ref-type="fig" rid="fig4">Figure 4B</xref>). Triple labeling with dynamin antibodies further revealed a 2.6-fold increase in dynamin signal (p = 0.01, n = 5, two-tailed t-test with Welch’s correction, <xref ref-type="fig" rid="fig4">Figure 4B</xref>). In super-resolution imaging, dynamins are shown in clusters along MTs in tau-loaded calyceal terminal (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). These results suggest that soluble WT h-tau can assemble MTs in presynaptic terminals, thereby sequestering cytosolic dynamins that are indispensable for SV endocytosis.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Wild-type (WT) human tau (h-tau) assembled microtubules (MTs) and increased bound-form dynamins in calyceal terminals.</title><p>(<bold>A</bold>) Immunofluorescence images of brainstem slices showing loaded WT h-tau (green, left, arrowhead) labeled with anti h-tau/Alexa Fluor 488 antibodies (green, left panel), newly assembled MTs labeled with anti-β3-tubulin/Alexa Fluor 647 antibodies (magenta, middle), and increased bound-form dynamin labeled with anti-dynamin 1/Alexa Fluor 568 antibodies (red, right panel). (<bold>B</bold>) Bar graphs showing immunofluorescence intensities of h-tau (green), β3-tubulin (magenta), and dynamin (red) relative to controls with no loading (black bars). WT h-tau loading significantly increased β3-tubulin (p = 0.0105) and dynamin 1 (p = 0.0109) intensity in terminals compared to control terminals without WT h-tau loading (n = 5 terminals from 5 slices for each data set, two-tailed unpaired t-test with Welch’s correction; *p &lt; 0.05, ***p &lt; 0.001).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw immunofluorescence images from <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mime-subtype="pptx" mimetype="application" xlink:href="elife-73542-fig4-data1-v2.pptx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Data from <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig4-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Super-resolution imaging of human tau (h-tau)-infused calyx of Held.</title><p>(<bold>A</bold>) Low magnification image of the terminal showing h-tau (green), β3-tubulin (blue), and dynamin 1 (red). Images were acquired on LSM900 with Airyscan 2 super-resolution module followed by 3D deconvolution. Scale bar, 5 µm. Corresponding 3D surface rendering image is shown on the right panel. (<bold>B</bold>) Expanded views of the delineated area in panel A, showing close localization of dynamin 1 with microtubule (MT) bundles in the presynaptic terminal infused with h-tau, and corresponding 3D surface rendering image (bottom panel). Scale bar, 1 µm.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw images from <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="pptx" mimetype="application" xlink:href="elife-73542-fig4-figsupp1-data1-v2.pptx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Effects of a formin mDia inhibitor on synaptic vesicle (SV) endocytosis and tau infusion on the quantal EPSCs.</title><p>(<bold>A</bold>) Formin mDia inhibitor SMIFH2 (50 µM) has no significant effect on SV endocytic rate (middle panel bar graphs, p = 0.45, n = 4) or exocytic magnitude (right panel bar graphs, p = 0.88, n = 4) at the calyx of Held of post-hearing mice (P13–14). Sample traces of capacitance changes evoked by a 20 ms pule with (red) or without (black) SMIFH2 are superimposed in the left panel. (<bold>B</bold>) Intra-terminal h-tau infusion had no effect on the mean amplitude (p = 0.08, t-test, n = 4) or frequency (p = 0.07, t-test, n = 4) of spontaneous miniature EPSCs. Left panel, sample trace 5 min before (control, upper trace) and 30 min after tau infusion (lower trace) in a simultaneous pre- and postsynaptic recording experiment.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Data from <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig4-figsupp2-v2.tif"/></fig></fig-group><p>Besides dynamins, MTs can bind to various other proteins. Among them, formin mDia can bind to MTs (<xref ref-type="bibr" rid="bib2">Bartolini and Gundersen, 2010</xref>) and involved in the endocytic scaffold functions together with F-actin, intersectin, and endophilin. Although acute depolymerization of F-actin (<xref ref-type="bibr" rid="bib40">Piriya Ananda Babu et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Eguchi et al., 2017</xref>) or genetic ablation of intersectin (<xref ref-type="bibr" rid="bib47">Sakaba et al., 2013</xref>) has no effect on SV endocytosis at the calyx of Held, the formin mDia inhibitor SMFH2 reportedly inhibits endocytosis at the calyx terminals in pre-hearing rats (postnatal days [P] 8–12) (<xref ref-type="bibr" rid="bib55">Soykan et al., 2017</xref>). We re-examined whether the drug might inhibit SV endocytosis at calyceal terminals in slices from post-hearing mice (P13–14). SMFH2 slightly prolonged SV endocytosis, but this effect was statistically insignificant (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Thus, formin unlikely makes substantial contribution to the marked endocytic slowing observed after intra-terminal tau loading (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>It may also be argued that binding of endophilin to MTs (<xref ref-type="bibr" rid="bib49">Schuske et al., 2003</xref>) might cause EPSC rundown since endophilin is involved in clathrin uncoating (<xref ref-type="bibr" rid="bib68">Watanabe et al., 2018</xref>), which is required for SV refilling with glutamate. If SV refilling during recycling is impaired, miniature EPSCs are decreased in amplitude and frequency (<xref ref-type="bibr" rid="bib62">Takami et al., 2017</xref>). However, neither amplitude nor frequency was affected by intra-terminal loading of tau (20 µM) (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). Thus, endophilin-MT binding unlikely underlies EPSC rundown by intra-terminal tau infusion (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s2-5"><title>An MT-dynamin-binding inhibitor peptide attenuates h-tau toxicities on SV endocytosis and synaptic transmission</title><p>To prevent toxic effects of h-tau on endocytosis and transmission, we searched for a dominant-negative (DN) peptide blocking MT-dynamin binding. Since the MT-binding domain of dynamins is unknown, we synthesized 11 peptides from the pleckstrin-homology (PH) domain and 11 peptides from the proline-rich domain of dynamin 1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>) and submitted them to the MT-dynamin 1-binding assay. Out of 22 peptides, one peptide corresponding to the amino acid sequence 560–571 of PH domain, which we named ‘PHDP5’, significantly inhibited the MT-dynamin 1 interaction (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and C</xref>). By SYPRO orange staining, dynamin 1 is found as an ~100 kDa band, 1.7% ± 0.4% in precipitates (ppts). In the presence of MT, dynamin 1 in ppts increased to 22.6% ± 2.4%, indicating sequestration of dynamin 1 by MTs. When PHDP5 was added to MT and dynamin 1, dynamin 1 in the ppt fraction decreased to 6.3% ± 2.4%, indicating that PHDP5 works as a DN peptide for inhibiting MT-dynamin interactions (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Dynamin 1 pleckstrin-homology (PH) domain peptide inhibited microtubule (MT)-dynamin 1 binding and prevented endocytic slowing and EPSC rundown caused by wild-type (WT) human tau (h-tau).</title><p>(<bold>A</bold>) <italic>Top</italic>, partial amino acid sequence of PH domain of mouse dynamin 1 indicating the sequence of the synthetic dodecapeptide PHDP5 (560–571). <italic>Left</italic>, SDS-PAGE of MT-dynamin 1-binding assay. S, supernatant; P, precipitates. Dyn1, dynamin 1. <italic>Right</italic>, quantification of MT-dynamin 1 interaction. The bars indicate the percentage of dynamin 1 found in precipitates relative to total amount. PHDP5 significantly inhibited MT-dynamin 1 interaction (**p &lt; 0.01, n = 3). (<bold>B</bold>) Presynaptic membrane capacitance records (superimposed) after loading h-tau alone (20 µM, red trace, taken from <xref ref-type="fig" rid="fig4">Figure 4B</xref>), h-tau co-loaded with DPHP5 (0.25 mM, blue) or scrambled DPHP5 (SDPHP5, green). DPHP5 alone (0.25 mM, black trace, 7 terminals from 7 slices) had no effect on capacitance changes compared to non-loading terminal controls (taken from <xref ref-type="fig" rid="fig3">Figure 3B</xref>). Bar graphs of endocytic rates (middle panel) indicate significant difference (*p &lt; 0.05, 7 terminals from 7 slices) between tau (red bar, 8 terminals from 8 slices) and DPHP5 + tau (blue, 7 terminals from 7 slices) as well as between SDPHP5 + tau (blue) and DPHP5 + tau (green, n = 6 terminals from 6 slices). The magnitudes of exocytic capacitance changes were not significantly different between the groups, recorded 25 min after rupture. (<bold>C</bold>) DPHP5 attenuated h-tau-induced EPSC rundown. The EPSC rundown after h-tau infusion (20 µM, red dashed line; data taken from <xref ref-type="fig" rid="fig1">Figure 1A</xref>) was attenuated by DPHP5 (1 mM) co-loaded with h-tau (filled circles) but not by scrambled DPHP5 peptide (SDPHP5, open triangles, 1 mM). DPHP5 alone (1 mM, open circles) had no effect on EPSC amplitude throughout. Bar graphs indicate EPSC amplitude (normalized to that before infusion) 30 min after infusion. Significant difference (**p &lt; 0.01) between tau and tau + DPHP5, between tau + DPHP5 and tau + SDPHP5. The difference between DPHP5 alone and DPHP5 + tau was not significant (p = 0.09), indicating the partial antagonistic effect of DPHP5 against h-tau-induced EPSC rundown.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Data from <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Data from <xref ref-type="fig" rid="fig5">Figure 5B and C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig5-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Images from <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mime-subtype="pptx" mimetype="application" xlink:href="elife-73542-fig5-data3-v2.pptx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>PHDP5 strongly inhibited dynamin 1 binding to microtubules (MTs).</title><p>(<bold>A</bold>) Peptide sequences in mouse dynamin 1 used in the dominant-negative (DN) peptide screening. In total, 24 peptides covering the pleckstrin-homology (PH) domain and the proline-rich domain were synthesized. (<bold>B</bold>) SDS-PAGE of the MT-binding assay, showing that PHDP5 strongly inhibits the MT-dynamin 1 binding (‘+Pep5’ in the top right panel). Since five peptides (peptide6, peptide8, peptide9, peptide10, peptide11) were insoluble in water or dimethyl sulfoxide, their effects were not tested. (<bold>C</bold>) Effects of the synthetic peptides at 1 mM on MT-dynamin 1 binding. Bar graphs indicate the percentage of dynamin 1 found in precipitates relative to total amount.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Images from <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="pptx" mimetype="application" xlink:href="elife-73542-fig5-figsupp1-data1-v2.pptx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Data from <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73542-fig5-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Pleckstrin-homology (PH) domain of dynamin 1 directly binds to microtubules.</title><p>(<bold>A</bold>) <italic>Left panels</italic>, glutathione transferase-tagged PH domain (GST-PH) labeled with HiLyte Fluor-555 (red, GST-PH) highly localized with fluorescent microtubules (green, MTs). Scale bar, 20 µm. <italic>Right panels</italic>, GST without PH did not co-localize with MTs. (<bold>B</bold>) Electron micrograph of negatively stained MTs (<italic>upper left panel</italic>), MTs plus GST-PH (<italic>upper middle panel</italic>), GST-PH alone (<italic>upper right panel</italic>), MTs plus GST (<italic>lower left</italic> panel), GST alone (<italic>lower right panel</italic>). GST-PH binds and crosslinks MTs. GST-PH forms larger complexes compared to GST. Scale bar, 200 nm.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Images from <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mime-subtype="pptx" mimetype="application" xlink:href="elife-73542-fig5-figsupp2-data1-v2.pptx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73542-fig5-figsupp2-v2.tif"/></fig></fig-group><p>A cryo-electron microscope study on dynamin 1 assembled on lipid membrane has revealed that PH domain is tucked up into dynamin structure in apo state, but upon GTP binding, exposed toward membrane by a conformational change (<xref ref-type="bibr" rid="bib28">Kong et al., 2018</xref>). In negatively stained electron micrographs, dynamin 1 is periodically arranged on the surface of MTs (<xref ref-type="bibr" rid="bib31">La et al., 2020</xref>), suggesting a helical polymerization like in dynamin-membrane interaction (<xref ref-type="bibr" rid="bib76">Zhang and Hinshaw, 2001</xref>). Therefore, PH domain including the putative-binding site PHDP5 is likely exposed toward MT surface. To examine whether PH domain of dynamin 1 can directly bind to MTs, immunofluorescence labeled MTs and glutathione transferase-tagged PH domain (GST-PH) were mixed and observed by confocal and electron microscopy (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). In confocal microscopic imaging, GST-PH co-localized with MTs, in contrast to controls, where MTs were mixed with GST alone (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>). These results were further confirmed in electron microscopic imaging, showing co-localizations of MTs and GST-PH (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>). Thus, dynamin 1 PH domain can associate with MTs, although it remains to be determined whether PHDP5 can directly bind to MTs.</p><p>Loading of PHDP5 (0.25 mM) alone in calyceal terminals had no effect on exo-endocytic capacitance changes, but when co-loaded with WT h-tau (20 µM), it significantly attenuated the h-tau-induced endocytic slowing (p &lt; 0.05, <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Scrambled PHDP5 peptide (0.25 mM) loaded as a control had no effect on h-tau-induced endocytic slowing. Like its effect on capacitance changes, intra-terminal infusion of PHDP5 alone (1 mM) did not affect EPSC amplitude, but when co-loaded with WT h-tau (20 µM), significantly attenuated the inhibitory effect of h-tau on EPSC amplitude (p &lt; 0.01, <xref ref-type="fig" rid="fig5">Figure 5C</xref>). Co-infusion of scrambled PHDP5 (1 mM) with h-tau (20 µM) did not affect the h-tau-induced EPSC rundown (p = 0.46). These results further support that WT h-tau causes dynamin deficiency via new assembly of MTs thereby impairing SV endocytosis and synaptic transmission. These results also highlight PHDP5 as a potential therapeutic tool for rescuing synaptic dysfunctions associated with AD or Parkinson’s disease (PD).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Using the calyx of Held in brainstem slices as an AD model for dissecting mammalian central excitatory synaptic transmission, we demonstrated that intra-terminal loading of WT h-tau impairs vesicle endocytosis and synaptic transmission via de novo MT assembly. Previous overexpression studies in cultured cells reported MT assembly by injection or overexpression of WT tau (<xref ref-type="bibr" rid="bib65">Thies and Mandelkow, 2007</xref>; <xref ref-type="bibr" rid="bib8">Drubin and Kirschner, 1986</xref>; <xref ref-type="bibr" rid="bib51">Shemesh et al., 2008</xref>) or phosphorylated tau (<xref ref-type="bibr" rid="bib50">Shahpasand et al., 2012</xref>; <xref ref-type="bibr" rid="bib33">Liu et al., 2007</xref>). Compared with overexpression, our whole-cell method allows targeted loading of molecules in presynaptic terminals at defined concentrations because of a large pipette-to-cell volume ratio (<xref ref-type="bibr" rid="bib43">Pusch and Neher, 1988</xref>). In postmortem brain tissue homogenates from AD patients, soluble tau content is estimated as 6 ng/μg of protein, which is eight times higher than controls (<xref ref-type="bibr" rid="bib27">Khatoon et al., 1992</xref>). Assuming protein contents in brain homogenate as 10%, 60 kDa tau concentration in AD patients’ brain is estimated as 10 µM. Since elevation of soluble tau concentration likely occurs mainly in axons and axon terminal compartments of neurons, soluble tau concentration in AD patients in presynaptic terminals can be higher than that. Our results at the calyx of Held suggest that excitatory synaptic transmission, in general, can be significantly impaired in such situations. In fact, the magnitude of EPSC rundown after WT h-tau loading is comparable to that caused by the clinical dose of general anesthetic isoflurane at the calyx of Held in slice (<xref ref-type="bibr" rid="bib67">Wang et al., 2020</xref>). In AD, tau pathology starts from the locus coeruleus in the brainstem and undergoes trans-synaptic propagation to hippocampal and neocortical neurons (<xref ref-type="bibr" rid="bib13">Goedert et al., 2014</xref>). Present results in our model synapse suggest that synaptic functions in such tau-propagation pathways can be severely affected at the early stage of AD.</p><p>Membrane capacitance measurements at the calyx of Held revealed the primary target of WT h-tau toxicity as SV endocytosis. Endocytic slowing impairs SV recycling and reuse, thereby inhibiting SV exocytosis, particularly in response to high-frequency stimulations (<xref ref-type="bibr" rid="bib72">Yamashita et al., 2005</xref>). The toxic effects of h-tau on SV endocytosis and synaptic transmission were prevented by nocodazole co-application. Together with the lack of toxicity of del-MTBD and toxic effects of taxol on synaptic transmission, these results suggest pathological roles of over-assembled MTs. Like WT h-tau, intra-terminal loading of WT α-synuclein slows SV endocytosis and impairs fidelity of high-frequency neurotransmission at the calyx of Held (<xref ref-type="bibr" rid="bib10">Eguchi et al., 2017</xref>). α-Synuclein toxicities can be rescued by blocking MT assembly with nocodazole or a photosensitive colchicine derivative PST-1. Thus, a common mechanism likely underlies synaptic dysfunctions in AD and PD. Compared with α-synuclein, h-tau toxicity is much stronger on endocytosis as well as on synaptic transmission. Thus, abnormal elevation of endogenous molecules beyond homeostatic level may cause AD and PD symptoms, like many other human diseases.</p><p>Although the GTPase dynamin is a well-known player in endocytic fission of SVs (<xref ref-type="bibr" rid="bib22">Hinshaw and Schmid, 1995</xref>; <xref ref-type="bibr" rid="bib63">Takei et al., 1995</xref>), it was originally discovered as an MT-binding protein (<xref ref-type="bibr" rid="bib52">Shpetner and Vallee, 1989</xref>). Subsequent studies indicated that this interaction upregulates dynamin’s GTPase activity (<xref ref-type="bibr" rid="bib35">Maeda et al., 1992</xref>; <xref ref-type="bibr" rid="bib53">Shpetner and Vallee, 1992</xref>) and can induce MT instability with dynamin 2 (<xref ref-type="bibr" rid="bib64">Tanabe and Takei, 2009</xref>) or stabilizes MT bundle formation with dynamin 1 (<xref ref-type="bibr" rid="bib31">La et al., 2020</xref>). However, the binding domain of dynamin remained unidentified. In this study, calyceal terminals loaded with WT h-tau showed a prominent increase in immunofluorescence signal intensity corresponding to bound dynamins. This was associated with an elevation in intra-terminal MTs, suggesting that newly assembled MTs induced by loaded h-tau sequestered cytosolic dynamins. These results well explain impairments of SV endocytosis by intra-terminal h-tau loading. Through synthetic peptide screening, we found that a dodecapeptide from dynamin 1 PH domain significantly inhibited the MT-dynamin interaction. This peptide PHDP5 is ~80% homologous to dynamin 3, another isoform involved in vesicle endocytosis (<xref ref-type="bibr" rid="bib44">Raimondi et al., 2011</xref>). Although direct binding of this peptide to MTs remains to be seen, it significantly rescued endocytic impairments and EPSC rundown induced by intra-terminal WT h-tau. Hence, MTs over-assembled by soluble WT h-tau proteins likely sequester free dynamins in presynaptic terminals, thereby blocking SV endocytosis and synaptic transmission, at least in this slice model. This dynamin sequestration mechanism by newly assembled MTs may also underlie the toxic effect of α-synuclein on SV endocytosis (<xref ref-type="bibr" rid="bib10">Eguchi et al., 2017</xref>) in PD.</p><p>Unlike WT h-tau, the FTDP-linked mutant tau does not affect SV endocytosis (<xref ref-type="bibr" rid="bib77">Zhou et al., 2017</xref>), but binds to both actin filaments (<xref ref-type="bibr" rid="bib12">Fulga et al., 2007</xref>) and the SV transmembrane protein synaptogyrin (<xref ref-type="bibr" rid="bib37">McInnes et al., 2018</xref>), thereby immobilizing SVs (<xref ref-type="bibr" rid="bib37">McInnes et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Zhou et al., 2017</xref>). WT-tau can also bind to synaptogyrin (<xref ref-type="bibr" rid="bib37">McInnes et al., 2018</xref>), but cannot bind to F-actins because of a difference in the MT-binding regions between FTDP mutant and WT tau (<xref ref-type="bibr" rid="bib8">Drubin and Kirschner, 1986</xref>; <xref ref-type="bibr" rid="bib46">Roger et al., 2004</xref>). However, WT h-tau can bind to various other macromolecules and organelles such as MTs, neurofilaments, and ribosomes (<xref ref-type="bibr" rid="bib19">Guo et al., 2017</xref>) as well as to synaptogyrin, thereby possibly immobilizing SVs. Recycling transport of SVs impaired by this mechanism might additionally contribute to the rundown of synaptic transmission remaining unblocked by the MT-dynamin blocker peptide.</p><p>In the absence of a powerful tool for alleviating symptoms associated with AD or PD, the calyx of Held slice model might provide a platform upon which therapeutic tools for rescuing synaptic dysfunctions can be pursued. The combination of this slice model with animal models could provide a new pathway toward rescuing neurological disorders.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>All experiments were performed in accordance with the guidelines of the Physiological Society of Japan and animal experiment regulations at Okinawa Institute of Science and Technology Graduate University.</p></sec><sec id="s4-2"><title>Recombinant human tau preparation</title><p>Human tau (h-tau) lacking the MT-binding domain (amino acid 244–367, del-MTBD) were produced by site-directed mutagenesis as previously reported (<xref ref-type="bibr" rid="bib69">Xie et al., 2014</xref>). Wild-type (WT) and del-MTBD mutant h-tau of 0N4R isoform were expressed in <italic>E. coli</italic>. (BL21/DE3) and purified as described previously (<xref ref-type="bibr" rid="bib21">Hasegawa et al., 1998</xref>) with minor modifications. Briefly, harvested bacteria expressing recombinant tau were lysed in homogenization buffer (50 mM PIPES, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, and 5 µg/ml Leupeptin, pH6.4), sonicated and centrifuged at 27,000× <italic>g</italic> for 15 min. Supernatants were charged onto phosphocellulose column (P11, Whatman). After washing with homogenization buffer containing 0.1 M NaCl, h-tau-containing fractions were eluted by the buffer containing 0.3 M NaCl. Subsequently, the proteins were precipitated by 50% saturated ammonium sulfate and re-solubilized in homogenization buffer containing 0.5 M NaCl and 1% 2-mercaptoethanol. After incubation at 100°C for 5 min, heatstable (soluble) fractions were obtained by centrifugation at 21,900× <italic>g</italic>, and fractionated by reverse phase high-performance liquid chromatography (RP-HPLC) using Cosmosyl Protein-R (Nacalai tesque Inc). Aliquots of h-tau containing fractions were lyophilized and stored at –80°C. Purified h-tau proteins were quantified by SDS-PAGE followed by Coomassie Brilliant Blue staining.</p></sec><sec id="s4-3"><title>Purification of recombinant human dynamin 1 protein</title><p>His-tagged human dynamin 1 was expressed using the Bac-to-Bac baculovirus expression system (Thermo Fisher Scientific, Waltham, MA) and purified as described previously (<xref ref-type="bibr" rid="bib70">Yamada et al., 2013</xref>). The purified dynamin solutions were concentrated using Centriplus YM50 (cat#4310; Merck-Millipore, Darmstadt, Germany).</p></sec><sec id="s4-4"><title>MT polymerization assay</title><p>Effects of tau and nocodazole on MT polymerization were tested using a Tubulin Polymerization Assay (Cytoskeleton Inc, Denver, CO). Briefly, purified WT or del-MTBD mutant h-tau (10 µM) were mixed with porcine tubulin (20 µM) in an assembly buffer at 37°C. Nocodazole was added to the mixture at 0 min of incubation. MT polymerization was fluorometrically assayed (excitation at 360 nm, emission at 465 nm) using Infinit F-200 Microplate Reader (TECAN, Männedorf/Switzerland) at 1 min intervals for 30 min. After incubation, resultant solutions were subjected to centrifugation at 100,000× <italic>g</italic> for 15 min at 20°C. Supernatants (free tubulin fraction) and pellets (MT fraction) were subjected to SDS-PAGE to quantify the amount of tubulin assembled into MTs.</p></sec><sec id="s4-5"><title>Peptide synthesis and LC-MS/MS analysis</title><p>The peptides were synthesized through conventional 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptide synthesis, onto preloaded Fmoc-alanine TCP-resins (Intavis Bioanalytical Instruments) using automated peptide synthesizer ResPep SL (Intavis Bioanalytical Instruments). All Fmoc-amino acids were purchased from Watanabe Chemical Industries and prepared at 0.5 M in <italic>N</italic>-methyl pyrrolidone (Wako Pure Chemical Industries). After synthesis, peptides were cleaved with (v/v/v) 92.5% TFA, 5% TIPS, and 2.5% water for 2 hr, precipitated using <italic>tert</italic>-butyl-methyl-ether at –30°C, pelleted, and resuspended in water before lyophilization (EYELA FDS-1000) overnight. All synthesized peptides’ purity and sequence were then confirmed by LC-MS/MS using a Q-Exactive Plus Orbitrap hybrid mass spectrometer (Thermo Scientific) equipped with Ultimate 3000 nano-HPLC system (Dionex), HTC-PAL autosampler (CTC Analytics), and nanoelectrospray ion source.</p></sec><sec id="s4-6"><title>MT-dynamin-binding assay</title><p>MT-binding assay was performed using Microtubule Binding Protein Spin Down Assay Kit (cat#BK029, Cytoskeleton Inc, Denver, CO). Briefly, 20 μl of 5 mg/ml tubulin in general tubulin buffer (GTB; 80 mM PIPES pH 7.0, 2 mM MgCl<sub>2</sub>, 0.5 mM EGTA) supplemented with 1 mM GTP were polymerized by adding 2 μl of cushion buffer (80 mM PIPES pH 7.0, 1 mM MgCl<sub>2</sub>, 1 mM EGTA, 60% glycerol) and incubated at 35°C for 20 min. MTs were stabilized with 20 μM Taxol. Taxol-stabilized MTs (2.5 μM) and dynamin 1 (1 μM) were incubated in GTB with or without 1 mM peptide at RT for 30 min. After incubation, the 50 μl of mixture was loaded on top of 100 μl cushion buffer supplemented with 20 μM Taxol, and then centrifuged at 100,000× <italic>g</italic> for 40 min at RT. After the ultracentrifugation, 50 μl of supernatant was taken and mixed with 10 μl of 5× sample buffer. The resultant pellet was resuspended with 50 μl of 1× sample buffer. Twenty μl of each sample was analyzed by SDS-PAGE and stained with SYPRO Orange. Protein bands were visualized using FLA-3000 (FUJIFILM Co. LTD, Tokyo, Japan).</p></sec><sec id="s4-7"><title>Immunocytochemical analysis</title><p>The following primary antibodies were used: anti-β3-tubulin (Synaptic System, #302304), anti-h-tau (BioLegend, #806501), anti-dynamin (Invitrogen, PA1-660). Secondary antibodies were goat IgG conjugated with Alexa Fluor 488, 568, or 647 (Thermo Fisher Scientific). Acute brainstem slices (175 μm in thickness, see below) were fixed with 4% paraformaldehyde in PBS for 30 min at 37°C and overnight at 4°C. On the following day, slices were rinsed three times in PBS, permeabilized in PBS containing 0.5% Triton X-100 (Tx-100; Nacalai Tesque) for 30 min and blocked in PBS containing 3% bovine serum albumin (BSA; Sigma-Aldrich) and 0.05% Tx-100 for 45 min. Slices were incubated overnight at 4°C with primary antibody diluted in PBS 0.05% Tx-100, 0.3% BSA. On the next day, slices were rinsed three times with PBS containing 0.05% Tx-100 for 10 min and incubated with corresponding secondary antibody diluted in PBS 0.05% Tx-100, 0.3% BSA for 1 hr at RT. Slices were further rinsed three times in PBS 0.05% Tx-100 for 10 min and finally washed in PBS for another 10 min. Finally, slices were mounted on glass slides (Matsunami) using liquid mounting medium (Ibidi) and sealed using nail polish. Confocal images were acquired on laser scanning microscopes (LSM780 or LSM900, Carl Zeiss) equipped with a Plan-apochromat 63× oil immersion objective (1.4 NA) and 488, 561, and 633 nm excitation laser lines. For quantifying fluorescence intensity levels, the region of interest was delimited around calyceal terminals, and background fluorescence was subtracted using ImageJ software.</p></sec><sec id="s4-8"><title>Purification of GST-proteins</title><p>The cDNA encoding PH domain (521–618 amino acids) of human dynamin 1 (NM_004408.4) (<xref ref-type="bibr" rid="bib17">Gu et al., 2010</xref>) were prepared by PCR and subcloned into the plasmid pGEX-6P vector. The resulting plasmid was transformed into bacterial BL21(DE3) pLysS strain for protein expression. The expression of GST-fusion proteins was induced by 0.1 mM isopropyl-1-thio-D-galactopyranoside at 37°C for 3–6 hr in LB media supplemented with 100 µg/ml ampicillin at A<sub>600</sub> = 0.8. GST-fusion proteins were then purified as described (<xref ref-type="bibr" rid="bib54">Slepnev et al., 2000</xref>). The nucleotide sequences of the constructs used in this study were verified with DNA sequence analysis. All the purified protein solutions (1–3 mg/ml) were stored at –80°C and thawed at 37°C before use.</p></sec><sec id="s4-9"><title>Microscopic observation of MT and GST-PH protein</title><p>GST or GST-PH was labeled using HiLyte Fluor-555 labeling kit according to manufacturer’s manual (cat#LK14, Dojindo Co. LTD, Kumamoto, Japan). HiLyte Fluor-555 labeled GST or GST-PH was mixed with non-labeled each protein at the ratio of 1:1.2. Flutax1-stabilized MTs (4.1 µM) and fluorescent GST or GST-PH at 11 µM were mixed in GTB containing 2 µM Flutax1 at 37°C for 60 min. Eight µl of the mixture was spotted on the slide glass and mounted with Fluoromount (cat#K024, Diagnostic BioSystems, Pleasanton, CA). Samples were examined using a spinning disc confocal microscope system (X-Light Confocal Imager; CREST OPTICS S.P.A., Rome, Italy) combined with an inverted microscope (IX-71; Olympus Optical Co., Ltd., Tokyo, Japan) and an iXon+ camera (Oxford Instruments, Oxfordshire, UK). The confocal system was controlled by MetaMorph software (Molecular Devices, Sunnyvale, CA). When necessary, images were processed using Adobe Photoshop CS3 or Illustrator CS3 software. For electron microscopic observation, samples were submitted to negative staining for imaging with a transmission electron microscope (H-7650, Hitachi High-Tech Corp., Tokyo, Japan) at 120 kV.</p></sec><sec id="s4-10"><title>Slice electrophysiology</title><p>After killing C57BL/6N mice of either sex (P13–15) by decapitation under isoflurane anesthesia, brainstems were isolated and transverse slices (175 μm thick) containing the medial nucleus of the trapezoid body (MNTB) were cut using a vibratome (VT1200S, Leica) in ice-cold artificial cerebrospinal fluid (aCSF, see below) with reduced Ca<sup>2+</sup> (0.1 mM) and increased Mg<sup>2+</sup> (3 mM) concentrations or sucrose-based aCSF (NaCl was replaced to 300 mM sucrose, concentrations of CaCl<sub>2</sub> and MgCl<sub>2</sub> was 0.1 and 6 mM, respectively). Slices were incubated for 1 hr at 36–37°C in standard aCSF containing (in mM): 125 NaCl, 2.5 KCl, 26 NaHCO<sub>3</sub>, 1.25 NaHPO<sub>4</sub>, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 glucose, 3 myo-inositol, 2 sodium pyruvate, and 0.5 sodium ascorbate (pH 7.4 when bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>, 310–320 mOsm), and maintained thereafter at RT (24–28°C).</p><p>Whole-cell recordings were made using a patch-clamp amplifier (Multiclamp 700A, Molecular Devices, Sunnyvale, CA, for pair recordings and EPC-10 USB, HEKA Elektronik, Germany, for presynaptic capacitance measurements) from the calyx of Held presynaptic terminals and postsynaptic MNTB principal neurons visually identified with a 60× or 40× water immersion objective (LUMPlanFL, Olympus) attached to an upright microscope (Axioskop2, Carl Zeiss, or BX51WI, Olympus, Japan). Data were acquired at a sampling rate of 50 kHz using pClamp (for Multiclamp 700A) or Patchmaster software (for EPC-10 USB) after online filtering at 5 kHz. The presynaptic pipette was pulled for the resistance of 7–10 MΩ and had a series resistance of 14–20 MΩ, which was compensated by 70% for its final value to be 7 MΩ. Resistance of the postsynaptic pipette was 5–7 MΩ, and its series resistance was 10–25 MΩ, which was compensated by up to 75% to a final value of 7 MΩ. The aCSF routinely contained picrotoxin (10 μM) and strychnine hydrochloride (0.5 μM) to block GABA<sub>A</sub> receptors and glycine receptors, respectively. Postsynaptic pipette solution contained (in mM): 130 CsCl, 5 EGTA, 1 MgCl<sub>2</sub>, 5 QX314-Cl, 10 HEPES (adjusted to pH 7.3–7.4 with CsOH). The presynaptic pipette solution contained (in mM): 105 K methanesulfonate, 30 KCl, 40 HEPES, 0.5 EGTA, 1 MgCl<sub>2</sub>, 12 phosphocreatine (Na salt), 3 ATP (Mg salt), 0.3 GTP (Na salt) (pH 7.3–7.4 adjusted with KOH, 315–320 mOsm).</p><p>In simultaneous presynaptic and postsynaptic whole-cell recordings, postsynaptic MNTB neurons were voltage-clamped at the holding potential of –70 mV, and EPSCs were evoked, at 0.1 or 1 Hz, by action potentials elicited by a depolarizing current (1 ms) injected in calyceal terminals. For intra-terminal loading of taxol (1 μM), it was diluted in presynaptic pipette solution from 5 mM DMSO stock for final DMSO concentration to be 0.02%. Likewise, nocodazole (20 μM, 0.1% DMSO) was included in presynaptic pipette solution. Presynaptic pipette solutions in nocodazole controls contained 0.1% DMSO. In simultaneous pre- and postsynaptic recordings, WT h-tau, del-MTBD tau, taxol, or synthetic peptides were loaded in calyceal terminals using the pipette perfusion technique (<xref ref-type="bibr" rid="bib23">Hori et al., 1999</xref>; <xref ref-type="bibr" rid="bib24">Hori and Takahashi, 2012</xref>). Briefly, a fine superfusion tube composed of plastic and glass tubes was installed in a presynaptic patch pipette. After backfilling the tube with pipette solutions containing proteins and/or peptides, it was inserted into a patch pipette with its tip 500–600 μm behind the tip of presynaptic patch pipette. After recording baseline EPSCs, the tube solution was delivered into presynaptic patch pipette with a positive pressure (8–10 psi) applied using a pico-pump.</p><p>Membrane capacitance (C<sub>m</sub>) measurements were made from calyx of Held presynaptic terminals in the whole-cell configuration at RT (<xref ref-type="bibr" rid="bib58">Sun and Wu, 2001</xref>; <xref ref-type="bibr" rid="bib72">Yamashita et al., 2005</xref>). Calyceal terminals were voltage-clamped at a holding potential of –80 mV, and a sinusoidal voltage command (1 kHz, 60 mV in peak-to-peak amplitude) was applied. To isolate presynaptic voltage-gated Ca<sup>2+</sup> currents (I<sub>Ca</sub>), the aCSF contained 10 mM tetraethylammonium chloride, 0.5 mM 4-aminopyridine, 1 µM tetrodotoxin, 10 µM bicuculline methiodide, and 0.5 µM strychnine hydrochloride. The presynaptic pipette solution contained (in mM): 125 Cs methanesulfonate, 30 CsCl, 10 HEPES, 0.5 EGTA, 12 disodium phosphocreatine, 3 MgATP, 1 MgCl<sub>2</sub>, 0.3 Na<sub>2</sub>GTP (pH 7.3 adjusted with CsOH, 315–320 mOsm). Tau or synthetic peptides were dissolved in pipette solution and backfilled into the pipette briefly after loading the tau-free pipette solution from the pipette tip. Care was taken to maintain series resistance &lt;16 MΩ to allow dialysis of the terminal with pipette solution. Recording pipette tips were coated with dental wax to minimize stray capacitance (4–5 pF). Single square pulse (−80 to 10 mV, 20 ms duration) was used to induce presynaptic I<sub>Ca</sub>. In these experiments, exocytic capacitance change (ΔCm) represents ~5 times larger number of SVs (estimated from ΔC<sub>m</sub> divided by C<sub>m</sub> of single SV) than that in the immediately releasable pool by presynaptic action potentials (estimated by the size of maximally evoked EPSCs divided by the size of miniature EPSCs). Membrane capacitance changes within 450 ms of square-pulse stimulation were excluded from analysis to avoid contamination by conductance-dependent capacitance artifacts (<xref ref-type="bibr" rid="bib72">Yamashita et al., 2005</xref>). To avoid the influence of capacitance drift on baseline, we removed data when the baseline drift measured 0–10 s before stimulation was over 5 fF/s. When the drift was 1–5 fF/s, we subtracted a linear regression line of the baseline from the data for the baseline correction. The endocytic rate was calculated from the slope of the normalized C<sub>m</sub> changes during the initial 10 s after the stimulation.</p></sec><sec id="s4-11"><title>Data analysis and statistics</title><p>Data were analyzed using IGOR Pro 6 (WaveMatrics), Excel 2016 (Microsoft), and StatPlus (AnalystSoft Inc) and KaleidaGraph for Macintosh, version 4.1 (Synergy Software Inc, Essex Junction, VT). All values are given as mean ± SEM. Differences were considered statistically significant at p &lt; 0.05 in paired or unpaired t-tests, one-way ANOVA with Scheffe post hoc test and repeated-measures two-way ANOVA with post hoc Scheffe test.</p></sec><sec id="s4-12"><title>Study approval</title><p>All experiments were carried out in accordance with the regulation and guidelines of Okinawa Institute of Science and Technology Graduate University (Approval number: 2021-347-00).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Funding acquisition, Investigation, Resources, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Resources, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Project administration, Resources, Supervision, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Investigation, Project administration, Resources, Supervision, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Data curation, Project administration, Supervision, Visualization, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments were performed in accordance with the guidelines of the Physiological Society of Japan and animal experiment regulations at Okinawa Institute of Science and Technology Graduate University.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-73542-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for All Figures.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Yasuo Ihara, Nobuyuki Nukina, and Takeshi Sakaba for comments and Patrick Stoney for editing this paper. We also thank Shota Okuda and Mikako Matsubara for their contributions in the early stage of this study, and Satoko Wada-Kakuda for technical assistant with in vitro analysis of tau. This research was supported by funding from Okinawa Institute of Science and Technology and from Technology (OIST) and Core Research for the Evolutional Science and Technology of Japan Science and Technology Agency (CREST) to TT, and by Scientific Research on Innovative Areas to TM (Brain Protein Aging and Dementia Control 26117004).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballatore</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders</article-title><source>Nature Reviews. Neuroscience</source><volume>8</volume><fpage>663</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1038/nrn2194</pub-id><pub-id pub-id-type="pmid">17684513</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartolini</surname><given-names>F</given-names></name><name><surname>Gundersen</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Formins and microtubules</article-title><source>Biochimica et Biophysica Acta</source><volume>1803</volume><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2009.07.006</pub-id><pub-id pub-id-type="pmid">19631698</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>Gustke</surname><given-names>N</given-names></name><name><surname>Drewes</surname><given-names>G</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding</article-title><source>Neuron</source><volume>11</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(93)90279-z</pub-id><pub-id pub-id-type="pmid">8393323</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>LI</given-names></name><name><surname>Frankfurter</surname><given-names>A</given-names></name><name><surname>Rebhun</surname><given-names>LI</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>The distribution of tau in the mammalian central nervous system</article-title><source>The Journal of Cell Biology</source><volume>101</volume><fpage>1371</fpage><lpage>1378</lpage><pub-id pub-id-type="doi">10.1083/jcb.101.4.1371</pub-id><pub-id pub-id-type="pmid">3930508</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunden</surname><given-names>KR</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Advances in tau-focused drug discovery for Alzheimer’s disease and related tauopathies</article-title><source>Nature Reviews. Drug Discovery</source><volume>8</volume><fpage>783</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1038/nrd2959</pub-id><pub-id pub-id-type="pmid">19794442</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Calignon</surname><given-names>A</given-names></name><name><surname>Polydoro</surname><given-names>M</given-names></name><name><surname>Suárez-Calvet</surname><given-names>M</given-names></name><name><surname>William</surname><given-names>C</given-names></name><name><surname>Adamowicz</surname><given-names>DH</given-names></name><name><surname>Kopeikina</surname><given-names>KJ</given-names></name><name><surname>Pitstick</surname><given-names>R</given-names></name><name><surname>Sahara</surname><given-names>N</given-names></name><name><surname>Ashe</surname><given-names>KH</given-names></name><name><surname>Carlson</surname><given-names>GA</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Propagation of tau pathology in a model of early Alzheimer’s disease</article-title><source>Neuron</source><volume>73</volume><fpage>685</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.033</pub-id><pub-id pub-id-type="pmid">22365544</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drechsel</surname><given-names>DN</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Cobb</surname><given-names>MH</given-names></name><name><surname>Kirschner</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau</article-title><source>Molecular Biology of the Cell</source><volume>3</volume><fpage>1141</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1091/mbc.3.10.1141</pub-id><pub-id pub-id-type="pmid">1421571</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drubin</surname><given-names>DG</given-names></name><name><surname>Kirschner</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Tau protein function in living cells</article-title><source>The Journal of Cell Biology</source><volume>103</volume><fpage>2739</fpage><lpage>2746</lpage><pub-id pub-id-type="doi">10.1083/jcb.103.6.2739</pub-id><pub-id pub-id-type="pmid">3098742</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebneth</surname><given-names>A</given-names></name><name><surname>Godemann</surname><given-names>R</given-names></name><name><surname>Stamer</surname><given-names>K</given-names></name><name><surname>Illenberger</surname><given-names>S</given-names></name><name><surname>Trinczek</surname><given-names>B</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer’s disease</article-title><source>The Journal of Cell Biology</source><volume>143</volume><fpage>777</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1083/jcb.143.3.777</pub-id><pub-id pub-id-type="pmid">9813097</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eguchi</surname><given-names>K</given-names></name><name><surname>Taoufiq</surname><given-names>Z</given-names></name><name><surname>Thorn-Seshold</surname><given-names>O</given-names></name><name><surname>Trauner</surname><given-names>D</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Wild-Type Monomeric α-Synuclein Can Impair Vesicle Endocytosis and Synaptic Fidelity via Tubulin Polymerization at the Calyx of Held</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>6043</fpage><lpage>6052</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0179-17.2017</pub-id><pub-id pub-id-type="pmid">28576942</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fein</surname><given-names>JA</given-names></name><name><surname>Sokolow</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Vinters</surname><given-names>HV</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Cole</surname><given-names>GM</given-names></name><name><surname>Gylys</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Co-localization of amyloid beta and tau pathology in Alzheimer’s disease synaptosomes</article-title><source>The American Journal of Pathology</source><volume>172</volume><fpage>1683</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2008.070829</pub-id><pub-id pub-id-type="pmid">18467692</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulga</surname><given-names>TA</given-names></name><name><surname>Elson-Schwab</surname><given-names>I</given-names></name><name><surname>Khurana</surname><given-names>V</given-names></name><name><surname>Steinhilb</surname><given-names>ML</given-names></name><name><surname>Spires</surname><given-names>TL</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Feany</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo</article-title><source>Nature Cell Biology</source><volume>9</volume><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/ncb1528</pub-id><pub-id pub-id-type="pmid">17187063</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Falcon</surname><given-names>B</given-names></name><name><surname>Clavaguera</surname><given-names>F</given-names></name><name><surname>Tolnay</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies</article-title><source>Current Neurology and Neuroscience Reports</source><volume>14</volume><elocation-id>495</elocation-id><pub-id pub-id-type="doi">10.1007/s11910-014-0495-z</pub-id><pub-id pub-id-type="pmid">25218483</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Götz</surname><given-names>J</given-names></name><name><surname>Ittner</surname><given-names>LM</given-names></name><name><surname>Fändrich</surname><given-names>M</given-names></name><name><surname>Schonrock</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods?</article-title><source>Journal of Alzheimer’s Disease</source><volume>14</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.3233/jad-2008-14410</pub-id><pub-id pub-id-type="pmid">18688093</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>SG</given-names></name><name><surname>Davies</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis</article-title><source>PNAS</source><volume>87</volume><fpage>5827</fpage><lpage>5831</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.15.5827</pub-id><pub-id pub-id-type="pmid">2116006</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name><name><surname>Tung</surname><given-names>YC</given-names></name><name><surname>Quinlan</surname><given-names>M</given-names></name><name><surname>Wisniewski</surname><given-names>HM</given-names></name><name><surname>Binder</surname><given-names>LI</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology</article-title><source>PNAS</source><volume>83</volume><fpage>4913</fpage><lpage>4917</lpage><pub-id pub-id-type="doi">10.1073/pnas.83.13.4913</pub-id><pub-id pub-id-type="pmid">3088567</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Yaddanapudi</surname><given-names>S</given-names></name><name><surname>Weins</surname><given-names>A</given-names></name><name><surname>Osborn</surname><given-names>T</given-names></name><name><surname>Reiser</surname><given-names>J</given-names></name><name><surname>Pollak</surname><given-names>M</given-names></name><name><surname>Hartwig</surname><given-names>J</given-names></name><name><surname>Sever</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Direct dynamin-actin interactions regulate the actin cytoskeleton</article-title><source>The EMBO Journal</source><volume>29</volume><fpage>3593</fpage><lpage>3606</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.249</pub-id><pub-id pub-id-type="pmid">20935625</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>JL</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>15317</fpage><lpage>15331</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.209296</pub-id><pub-id pub-id-type="pmid">21372138</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Noble</surname><given-names>W</given-names></name><name><surname>Hanger</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Roles of tau protein in health and disease</article-title><source>Acta Neuropathologica</source><volume>133</volume><fpage>665</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1007/s00401-017-1707-9</pub-id><pub-id pub-id-type="pmid">28386764</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>A</given-names></name><name><surname>Oguchi</surname><given-names>K</given-names></name><name><surname>Okabe</surname><given-names>S</given-names></name><name><surname>Kuno</surname><given-names>J</given-names></name><name><surname>Terada</surname><given-names>S</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Sato-Yoshitake</surname><given-names>R</given-names></name><name><surname>Takei</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Hirokawa</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Altered microtubule organization in small-calibre axons of mice lacking tau protein</article-title><source>Nature</source><volume>369</volume><fpage>488</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1038/369488a0</pub-id><pub-id pub-id-type="pmid">8202139</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>MJ</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly</article-title><source>FEBS Letters</source><volume>437</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(98)01217-4</pub-id><pub-id pub-id-type="pmid">9824291</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinshaw</surname><given-names>JE</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding</article-title><source>Nature</source><volume>374</volume><fpage>190</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1038/374190a0</pub-id><pub-id pub-id-type="pmid">7877694</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Presynaptic mechanism for phorbol ester-induced synaptic potentiation</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>7262</fpage><lpage>7267</lpage><pub-id pub-id-type="pmid">10460232</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Kinetics of synaptic vesicle refilling with neurotransmitter glutamate</article-title><source>Neuron</source><volume>76</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.013</pub-id><pub-id pub-id-type="pmid">23141063</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ittner</surname><given-names>LM</given-names></name><name><surname>Ke</surname><given-names>YD</given-names></name><name><surname>Delerue</surname><given-names>F</given-names></name><name><surname>Bi</surname><given-names>M</given-names></name><name><surname>Gladbach</surname><given-names>A</given-names></name><name><surname>van Eersel</surname><given-names>J</given-names></name><name><surname>Wölfing</surname><given-names>H</given-names></name><name><surname>Chieng</surname><given-names>BC</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name><name><surname>Napier</surname><given-names>IA</given-names></name><name><surname>Eckert</surname><given-names>A</given-names></name><name><surname>Staufenbiel</surname><given-names>M</given-names></name><name><surname>Hardeman</surname><given-names>E</given-names></name><name><surname>Götz</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models</article-title><source>Cell</source><volume>142</volume><fpage>387</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.06.036</pub-id><pub-id pub-id-type="pmid">20655099</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kar</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>MJ</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Amos</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Repeat motifs of tau bind to the insides of microtubules in the absence of taxol</article-title><source>The EMBO Journal</source><volume>22</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg001</pub-id><pub-id pub-id-type="pmid">12505985</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatoon</surname><given-names>S</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Brain levels of microtubule-associated protein tau are elevated in Alzheimer’s disease: a radioimmuno-slot-blot assay for nanograms of the protein</article-title><source>Journal of Neurochemistry</source><volume>59</volume><fpage>750</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1992.tb09432.x</pub-id><pub-id pub-id-type="pmid">1629745</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>L</given-names></name><name><surname>Sochacki</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Canagarajah</surname><given-names>B</given-names></name><name><surname>Kehr</surname><given-names>AD</given-names></name><name><surname>Rice</surname><given-names>WJ</given-names></name><name><surname>Strub</surname><given-names>M-P</given-names></name><name><surname>Taraska</surname><given-names>JW</given-names></name><name><surname>Hinshaw</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cryo-EM of the dynamin polymer assembled on lipid membrane</article-title><source>Nature</source><volume>560</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0378-6</pub-id><pub-id pub-id-type="pmid">30069048</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koss</surname><given-names>DJ</given-names></name><name><surname>Jones</surname><given-names>G</given-names></name><name><surname>Cranston</surname><given-names>A</given-names></name><name><surname>Gardner</surname><given-names>H</given-names></name><name><surname>Kanaan</surname><given-names>NM</given-names></name><name><surname>Platt</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline</article-title><source>Acta Neuropathologica</source><volume>132</volume><fpage>875</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1007/s00401-016-1632-3</pub-id><pub-id pub-id-type="pmid">27770234</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>A</given-names></name><name><surname>Misonou</surname><given-names>H</given-names></name><name><surname>Matsuyama</surname><given-names>M</given-names></name><name><surname>Nomori</surname><given-names>A</given-names></name><name><surname>Wada-Kakuda</surname><given-names>S</given-names></name><name><surname>Takashima</surname><given-names>A</given-names></name><name><surname>Kawata</surname><given-names>M</given-names></name><name><surname>Murayama</surname><given-names>S</given-names></name><name><surname>Ihara</surname><given-names>Y</given-names></name><name><surname>Miyasaka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distribution of endogenous normal tau in the mouse brain</article-title><source>The Journal of Comparative Neurology</source><volume>527</volume><fpage>985</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1002/cne.24577</pub-id><pub-id pub-id-type="pmid">30408165</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La</surname><given-names>TM</given-names></name><name><surname>Tachibana</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S-A</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Seiriki</surname><given-names>S</given-names></name><name><surname>Nagaoka</surname><given-names>H</given-names></name><name><surname>Takashima</surname><given-names>E</given-names></name><name><surname>Takeda</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>D</given-names></name><name><surname>Makino</surname><given-names>S-I</given-names></name><name><surname>Asanuma</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Ishibe</surname><given-names>S</given-names></name><name><surname>Sakane</surname><given-names>A</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>J</given-names></name><name><surname>Takei</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dynamin 1 is important for microtubule organization and stabilization in glomerular podocytes</article-title><source>FASEB Journal</source><volume>34</volume><fpage>16449</fpage><lpage>16463</lpage><pub-id pub-id-type="doi">10.1096/fj.202001240RR</pub-id><pub-id pub-id-type="pmid">33070431</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>VM-Y</given-names></name><name><surname>Brunden</surname><given-names>KR</given-names></name><name><surname>Hutton</surname><given-names>M</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>1</volume><elocation-id>a006437</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a006437</pub-id><pub-id pub-id-type="pmid">22229117</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Tung</surname><given-names>E-J</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name><name><surname>Gong</surname><given-names>C-X</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation</article-title><source>The European Journal of Neuroscience</source><volume>26</volume><fpage>3429</fpage><lpage>3436</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05955.x</pub-id><pub-id pub-id-type="pmid">18052981</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Drouet</surname><given-names>V</given-names></name><name><surname>Wu</surname><given-names>JW</given-names></name><name><surname>Witter</surname><given-names>MP</given-names></name><name><surname>Small</surname><given-names>SA</given-names></name><name><surname>Clelland</surname><given-names>C</given-names></name><name><surname>Duff</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Trans-synaptic spread of tau pathology in vivo</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e31302</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031302</pub-id><pub-id pub-id-type="pmid">22312444</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Nakata</surname><given-names>T</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name><name><surname>Sato-Yoshitake</surname><given-names>R</given-names></name><name><surname>Hirokawa</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Interaction of dynamin with microtubules: its structure and GTPase activity investigated by using highly purified dynamin</article-title><source>Molecular Biology of the Cell</source><volume>3</volume><fpage>1181</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1091/mbc.3.10.1181</pub-id><pub-id pub-id-type="pmid">1421574</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Sahara</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Murayama</surname><given-names>M</given-names></name><name><surname>Yoshiike</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Miyasaka</surname><given-names>T</given-names></name><name><surname>Murayama</surname><given-names>S</given-names></name><name><surname>Ikai</surname><given-names>A</given-names></name><name><surname>Takashima</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Granular tau oligomers as intermediates of tau filaments</article-title><source>Biochemistry</source><volume>46</volume><fpage>3856</fpage><lpage>3861</lpage><pub-id pub-id-type="doi">10.1021/bi061359o</pub-id><pub-id pub-id-type="pmid">17338548</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>J</given-names></name><name><surname>Wierda</surname><given-names>K</given-names></name><name><surname>Snellinx</surname><given-names>A</given-names></name><name><surname>Bounti</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y-C</given-names></name><name><surname>Stancu</surname><given-names>I-C</given-names></name><name><surname>Apóstolo</surname><given-names>N</given-names></name><name><surname>Gevaert</surname><given-names>K</given-names></name><name><surname>Dewachter</surname><given-names>I</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name><name><surname>De Wit</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau</article-title><source>Neuron</source><volume>97</volume><fpage>823</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.01.022</pub-id><pub-id pub-id-type="pmid">29398363</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Vossel</surname><given-names>K</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The many faces of tau</article-title><source>Neuron</source><volume>70</volume><fpage>410</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.04.009</pub-id><pub-id pub-id-type="pmid">21555069</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudher</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Newman</surname><given-names>TA</given-names></name><name><surname>Mildren</surname><given-names>P</given-names></name><name><surname>Jukes</surname><given-names>JP</given-names></name><name><surname>Squire</surname><given-names>A</given-names></name><name><surname>Mears</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>JA</given-names></name><name><surname>Berg</surname><given-names>S</given-names></name><name><surname>MacKay</surname><given-names>D</given-names></name><name><surname>Asuni</surname><given-names>AA</given-names></name><name><surname>Bhat</surname><given-names>R</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila</article-title><source>Molecular Psychiatry</source><volume>9</volume><fpage>522</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1038/sj.mp.4001483</pub-id><pub-id pub-id-type="pmid">14993907</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piriya Ananda Babu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H-Y</given-names></name><name><surname>Eguchi</surname><given-names>K</given-names></name><name><surname>Guillaud</surname><given-names>L</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microtubule and Actin Differentially Regulate Synaptic Vesicle Cycling to Maintain High-Frequency Neurotransmission</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1571-19.2019</pub-id><pub-id pub-id-type="pmid">31767677</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polydoro</surname><given-names>M</given-names></name><name><surname>Dzhala</surname><given-names>VI</given-names></name><name><surname>Pooler</surname><given-names>AM</given-names></name><name><surname>Nicholls</surname><given-names>SB</given-names></name><name><surname>McKinney</surname><given-names>AP</given-names></name><name><surname>Sanchez</surname><given-names>L</given-names></name><name><surname>Pitstick</surname><given-names>R</given-names></name><name><surname>Carlson</surname><given-names>GA</given-names></name><name><surname>Staley</surname><given-names>KJ</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer’s disease model</article-title><source>Acta Neuropathologica</source><volume>127</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1215-5</pub-id><pub-id pub-id-type="pmid">24271788</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pooler</surname><given-names>AM</given-names></name><name><surname>Phillips</surname><given-names>EC</given-names></name><name><surname>Lau</surname><given-names>DHW</given-names></name><name><surname>Noble</surname><given-names>W</given-names></name><name><surname>Hanger</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Physiological release of endogenous tau is stimulated by neuronal activity</article-title><source>EMBO Reports</source><volume>14</volume><fpage>389</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/embor.2013.15</pub-id><pub-id pub-id-type="pmid">23412472</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pusch</surname><given-names>M</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Rates of diffusional exchange between small cells and a measuring patch pipette</article-title><source>Pflugers Archiv</source><volume>411</volume><fpage>204</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1007/BF00582316</pub-id><pub-id pub-id-type="pmid">2451806</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimondi</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>SM</given-names></name><name><surname>Lou</surname><given-names>X</given-names></name><name><surname>Armbruster</surname><given-names>M</given-names></name><name><surname>Paradise</surname><given-names>S</given-names></name><name><surname>Giovedi</surname><given-names>S</given-names></name><name><surname>Messa</surname><given-names>M</given-names></name><name><surname>Kono</surname><given-names>N</given-names></name><name><surname>Takasaki</surname><given-names>J</given-names></name><name><surname>Cappello</surname><given-names>V</given-names></name><name><surname>O’Toole</surname><given-names>E</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Overlapping role of dynamin isoforms in synaptic vesicle endocytosis</article-title><source>Neuron</source><volume>70</volume><fpage>1100</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.04.031</pub-id><pub-id pub-id-type="pmid">21689597</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberson</surname><given-names>ED</given-names></name><name><surname>Scearce-Levie</surname><given-names>K</given-names></name><name><surname>Palop</surname><given-names>JJ</given-names></name><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>IH</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Gerstein</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>G-Q</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model</article-title><source>Science (New York, N.Y.)</source><volume>316</volume><fpage>750</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1126/science.1141736</pub-id><pub-id pub-id-type="pmid">17478722</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>B</given-names></name><name><surname>Al-Bassam</surname><given-names>J</given-names></name><name><surname>Dehmelt</surname><given-names>L</given-names></name><name><surname>Milligan</surname><given-names>RA</given-names></name><name><surname>Halpain</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>MAP2c, but not tau, binds and bundles F-actin via its microtubule binding domain</article-title><source>Current Biology</source><volume>14</volume><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.01.058</pub-id><pub-id pub-id-type="pmid">15028210</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaba</surname><given-names>T</given-names></name><name><surname>Kononenko</surname><given-names>NL</given-names></name><name><surname>Bacetic</surname><given-names>J</given-names></name><name><surname>Pechstein</surname><given-names>A</given-names></name><name><surname>Schmoranzer</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Barth</surname><given-names>H</given-names></name><name><surname>Shupliakov</surname><given-names>O</given-names></name><name><surname>Kobler</surname><given-names>O</given-names></name><name><surname>Aktories</surname><given-names>K</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fast neurotransmitter release regulated by the endocytic scaffold intersectin</article-title><source>PNAS</source><volume>110</volume><fpage>8266</fpage><lpage>8271</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219234110</pub-id><pub-id pub-id-type="pmid">23633571</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santacruz</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Spires</surname><given-names>T</given-names></name><name><surname>Paulson</surname><given-names>J</given-names></name><name><surname>Kotilinek</surname><given-names>L</given-names></name><name><surname>Ingelsson</surname><given-names>M</given-names></name><name><surname>Guimaraes</surname><given-names>A</given-names></name><name><surname>DeTure</surname><given-names>M</given-names></name><name><surname>Ramsden</surname><given-names>M</given-names></name><name><surname>McGowan</surname><given-names>E</given-names></name><name><surname>Forster</surname><given-names>C</given-names></name><name><surname>Yue</surname><given-names>M</given-names></name><name><surname>Orne</surname><given-names>J</given-names></name><name><surname>Janus</surname><given-names>C</given-names></name><name><surname>Mariash</surname><given-names>A</given-names></name><name><surname>Kuskowski</surname><given-names>M</given-names></name><name><surname>Hyman</surname><given-names>B</given-names></name><name><surname>Hutton</surname><given-names>M</given-names></name><name><surname>Ashe</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tau suppression in a neurodegenerative mouse model improves memory function</article-title><source>Science (New York, N.Y.)</source><volume>309</volume><fpage>476</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1126/science.1113694</pub-id><pub-id pub-id-type="pmid">16020737</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuske</surname><given-names>KR</given-names></name><name><surname>Richmond</surname><given-names>JE</given-names></name><name><surname>Matthies</surname><given-names>DS</given-names></name><name><surname>Davis</surname><given-names>WS</given-names></name><name><surname>Runz</surname><given-names>S</given-names></name><name><surname>Rube</surname><given-names>DA</given-names></name><name><surname>van der Bliek</surname><given-names>AM</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin</article-title><source>Neuron</source><volume>40</volume><fpage>749</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(03)00667-6</pub-id><pub-id pub-id-type="pmid">14622579</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahpasand</surname><given-names>K</given-names></name><name><surname>Uemura</surname><given-names>I</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Hata</surname><given-names>K</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Toyoshima</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Hisanaga</surname><given-names>S-I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer’s disease</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>2430</fpage><lpage>2441</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5927-11.2012</pub-id><pub-id pub-id-type="pmid">22396417</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shemesh</surname><given-names>OA</given-names></name><name><surname>Erez</surname><given-names>H</given-names></name><name><surname>Ginzburg</surname><given-names>I</given-names></name><name><surname>Spira</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Tau-induced traffic jams reflect organelles accumulation at points of microtubule polar mismatching</article-title><source>Traffic (Copenhagen, Denmark)</source><volume>9</volume><fpage>458</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2007.00695.x</pub-id><pub-id pub-id-type="pmid">18182010</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shpetner</surname><given-names>HS</given-names></name><name><surname>Vallee</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules</article-title><source>Cell</source><volume>59</volume><fpage>421</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(89)90027-5</pub-id><pub-id pub-id-type="pmid">2529977</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shpetner</surname><given-names>HS</given-names></name><name><surname>Vallee</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Dynamin is a GTPase stimulated to high levels of activity by microtubules</article-title><source>Nature</source><volume>355</volume><fpage>733</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1038/355733a0</pub-id><pub-id pub-id-type="pmid">1311055</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slepnev</surname><given-names>VI</given-names></name><name><surname>Ochoa</surname><given-names>GC</given-names></name><name><surname>Butler</surname><given-names>MH</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tandem arrangement of the clathrin and AP-2 binding domains in amphiphysin 1 and disruption of clathrin coat function by amphiphysin fragments comprising these sites</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>17583</fpage><lpage>17589</lpage><pub-id pub-id-type="doi">10.1074/jbc.M910430199</pub-id><pub-id pub-id-type="pmid">10748223</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soykan</surname><given-names>T</given-names></name><name><surname>Kaempf</surname><given-names>N</given-names></name><name><surname>Sakaba</surname><given-names>T</given-names></name><name><surname>Vollweiter</surname><given-names>D</given-names></name><name><surname>Goerdeler</surname><given-names>F</given-names></name><name><surname>Puchkov</surname><given-names>D</given-names></name><name><surname>Kononenko</surname><given-names>NL</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synaptic Vesicle Endocytosis Occurs on Multiple Timescales and Is Mediated by Formin-Dependent Actin Assembly</article-title><source>Neuron</source><volume>93</volume><fpage>854</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.011</pub-id><pub-id pub-id-type="pmid">28231467</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tau pathology and neurodegeneration</article-title><source>The Lancet. Neurology</source><volume>12</volume><fpage>609</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(13)70090-5</pub-id><pub-id pub-id-type="pmid">23684085</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamer</surname><given-names>K</given-names></name><name><surname>Vogel</surname><given-names>R</given-names></name><name><surname>Thies</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress</article-title><source>The Journal of Cell Biology</source><volume>156</volume><fpage>1051</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1083/jcb.200108057</pub-id><pub-id pub-id-type="pmid">11901170</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>JY</given-names></name><name><surname>Wu</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Fast kinetics of exocytosis revealed by simultaneous measurements of presynaptic capacitance and postsynaptic currents at a central synapse</article-title><source>Neuron</source><volume>30</volume><fpage>171</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00271-9</pub-id><pub-id pub-id-type="pmid">11343653</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydow</surname><given-names>A</given-names></name><name><surname>Van der Jeugd</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>F</given-names></name><name><surname>Ahmed</surname><given-names>T</given-names></name><name><surname>Balschun</surname><given-names>D</given-names></name><name><surname>Petrova</surname><given-names>O</given-names></name><name><surname>Drexler</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Rune</surname><given-names>G</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name><name><surname>D’Hooge</surname><given-names>R</given-names></name><name><surname>Alzheimer</surname><given-names>C</given-names></name><name><surname>Mandelkow</surname><given-names>E-M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>2511</fpage><lpage>2525</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5245-10.2011</pub-id><pub-id pub-id-type="pmid">21325519</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>H-C</given-names></name><name><surname>Serrano-Pozo</surname><given-names>A</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Frosch</surname><given-names>MP</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system</article-title><source>The American Journal of Pathology</source><volume>181</volume><fpage>1426</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.06.033</pub-id><pub-id pub-id-type="pmid">22867711</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><chapter-title>Patch-Clamp Recording Method in Slices for Studying Presynaptic Mechanisms</chapter-title><person-group person-group-type="editor"><name><surname>Okada</surname><given-names>Yasunobu</given-names></name></person-group><source>Patch Clamp Techniques</source><publisher-name>Springer Tokyo</publisher-name><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1007/978-4-431-53993-3</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takami</surname><given-names>C</given-names></name><name><surname>Eguchi</surname><given-names>K</given-names></name><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of vesicular glutamate leakage on synaptic transmission at the calyx of Held</article-title><source>The Journal of Physiology</source><volume>595</volume><fpage>1263</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1113/JP273467</pub-id><pub-id pub-id-type="pmid">27801501</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>K</given-names></name><name><surname>McPherson</surname><given-names>PS</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals</article-title><source>Nature</source><volume>374</volume><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/374186a0</pub-id><pub-id pub-id-type="pmid">7877693</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanabe</surname><given-names>K</given-names></name><name><surname>Takei</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant</article-title><source>The Journal of Cell Biology</source><volume>185</volume><fpage>939</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1083/jcb.200803153</pub-id><pub-id pub-id-type="pmid">19528294</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thies</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>2896</fpage><lpage>2907</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4674-06.2007</pub-id><pub-id pub-id-type="pmid">17360912</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vossel</surname><given-names>KA</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Brodbeck</surname><given-names>J</given-names></name><name><surname>Daub</surname><given-names>AC</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Finkbeiner</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>B</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Tau reduction prevents Abeta-induced defects in axonal transport</article-title><source>Science (New York, N.Y.)</source><volume>330</volume><elocation-id>198</elocation-id><pub-id pub-id-type="doi">10.1126/science.1194653</pub-id><pub-id pub-id-type="pmid">20829454</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Eguchi</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Frequency-Dependent Block of Excitatory Neurotransmission by Isoflurane via Dual Presynaptic Mechanisms</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>4103</fpage><lpage>4115</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2946-19.2020</pub-id><pub-id pub-id-type="pmid">32327530</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Mamer</surname><given-names>LE</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Luvsanjav</surname><given-names>D</given-names></name><name><surname>Eisen</surname><given-names>J</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Söhl-Kielczynski</surname><given-names>B</given-names></name><name><surname>Fenske</surname><given-names>P</given-names></name><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Synaptojanin and Endophilin Mediate Neck Formation during Ultrafast Endocytosis</article-title><source>Neuron</source><volume>98</volume><fpage>1184</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.005</pub-id><pub-id pub-id-type="pmid">29953872</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Miyasaka</surname><given-names>T</given-names></name><name><surname>Yoshimura</surname><given-names>S</given-names></name><name><surname>Hatsuta</surname><given-names>H</given-names></name><name><surname>Yoshina</surname><given-names>S</given-names></name><name><surname>Kage-Nakadai</surname><given-names>E</given-names></name><name><surname>Mitani</surname><given-names>S</given-names></name><name><surname>Murayama</surname><given-names>S</given-names></name><name><surname>Ihara</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The homologous carboxyl-terminal domains of microtubule-associated protein 2 and TAU induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e89796</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0089796</pub-id><pub-id pub-id-type="pmid">24587039</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>A</given-names></name><name><surname>Okazaki</surname><given-names>N</given-names></name><name><surname>Tago</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Oda</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Tomizawa</surname><given-names>K</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Takei</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Stabilization of actin bundles by a dynamin 1/cortactin ring complex is necessary for growth cone filopodia</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>4514</fpage><lpage>4526</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2762-12.2013</pub-id><pub-id pub-id-type="pmid">23467367</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Holth</surname><given-names>JK</given-names></name><name><surname>Liao</surname><given-names>F</given-names></name><name><surname>Stewart</surname><given-names>FR</given-names></name><name><surname>Mahan</surname><given-names>TE</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Cirrito</surname><given-names>JR</given-names></name><name><surname>Patel</surname><given-names>TK</given-names></name><name><surname>Hochgräfe</surname><given-names>K</given-names></name><name><surname>Mandelkow</surname><given-names>E-M</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuronal activity regulates extracellular tau in vivo</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>387</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1084/jem.20131685</pub-id><pub-id pub-id-type="pmid">24534188</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Hige</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Vesicle endocytosis requires dynamin-dependent GTP hydrolysis at a fast CNS synapse</article-title><source>Science (New York, N.Y.)</source><volume>307</volume><fpage>124</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1126/science.1103631</pub-id><pub-id pub-id-type="pmid">15637282</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Ihara</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau</article-title><source>Journal of Neurochemistry</source><volume>61</volume><fpage>1183</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1993.tb03642.x</pub-id><pub-id pub-id-type="pmid">8360683</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshiyama</surname><given-names>Y</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>S-M</given-names></name><name><surname>Iwata</surname><given-names>N</given-names></name><name><surname>Saido</surname><given-names>TC</given-names></name><name><surname>Maeda</surname><given-names>J</given-names></name><name><surname>Suhara</surname><given-names>T</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model</article-title><source>Neuron</source><volume>53</volume><fpage>337</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.01.010</pub-id><pub-id pub-id-type="pmid">17270732</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Peterhoff</surname><given-names>C</given-names></name><name><surname>Duff</surname><given-names>K</given-names></name><name><surname>Nixon</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>1682</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5242-07.2008</pub-id><pub-id pub-id-type="pmid">18272688</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Hinshaw</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Three-dimensional reconstruction of dynamin in the constricted state</article-title><source>Nature Cell Biology</source><volume>3</volume><fpage>922</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1038/ncb1001-922</pub-id><pub-id pub-id-type="pmid">11584275</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>McInnes</surname><given-names>J</given-names></name><name><surname>Wierda</surname><given-names>K</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Herrmann</surname><given-names>AG</given-names></name><name><surname>Jackson</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>Y-C</given-names></name><name><surname>Swerts</surname><given-names>J</given-names></name><name><surname>Beyens</surname><given-names>J</given-names></name><name><surname>Miskiewicz</surname><given-names>K</given-names></name><name><surname>Vilain</surname><given-names>S</given-names></name><name><surname>Dewachter</surname><given-names>I</given-names></name><name><surname>Moechars</surname><given-names>D</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>De Wit</surname><given-names>J</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tau association with synaptic vesicles causes presynaptic dysfunction</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15295</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15295</pub-id><pub-id pub-id-type="pmid">28492240</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73542.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brose</surname><given-names>Nils</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a7f6w43</institution-id><institution>Max Planck Institute of Experimental Medicine</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.09.13.460074" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.13.460074"/></front-stub><body><p>This study provides an interesting new insight into the synaptic disease mechanisms of tauopathies. The paper is based on a technically very rigorous dataset indicating that increased levels of soluble Tau impair pre-synaptic endocytosis and, consequently, neurotransmission by sequestering Dynamin-1 on microtubules. The findings are of major relevance for basic neuronal cell biology and translational neuroscience alike.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73542.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a7f6w43</institution-id><institution>Max Planck Institute of Experimental Medicine</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.13.460074">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.09.13.460074v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Microtubule assembly by soluble tau impairs vesicle endocytosis and excitatory neurotransmission via dynamin sequestration in Alzheimer's disease synapse model&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Suzanne Pfeffer as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted the comments below to help you prepare a revised submission.</p><p>Essential revisions - Additional Experiments:</p><p>1. The PH domain-derived peptide used for the experiments documented in Figure 5 is part of a tightly folded domain (i.e. as a loop-β-fold, see PDB 2YS1). No data are presented to demonstrate that the PH domain of Dynamin-1 indeed binds to microtubules directly (or indirectly) in vitro and in vivo (or in living neurons). Indeed, it is questionable that the short PHDP5 12-mer peptide, when presented outside its sequence context within the PH domain folds into its native structure and exhibits its physiological set of interactions. A thorough biochemical characterization of the association of Dynamin-1 with microtubules is a prerequisite to interpret the results shown in Figure 5, which indicate a partial rescue of Tau induced endocytic defects by a rather high concentration (1 mM) of PHDP5 peptide. Moreover, additional complementary tools (e.g. expression or injection of WT vs. mutant forms of Dynamin-1 or its PH domain) should be used to assess the role of the alleged microtubule binding site in Dynamin-1 that is proposed to mediate the effects of Tau on pre-synaptic function. These issues need to be addressed experimentally.</p><p>2. The link between elevated microtubule assembly and Dynamin-1 recruitment discussed in the context of Figure 4 remains loose. In the confocal images of fluorescently labeled calyces in Figure 4A, beta3-Tubulin and Dynamin-1 are shown. Is there direct evidence to show that the alleged increase in beta3-Tubulin levels is due to elevated microtubule assembly or stability elicited by microinjected tau? Confocal resolution is insufficient to differentiate Dynamin-1 located in the pre-synaptic cytoplasm from Dynamin-1 bound to microtubules. Super-resolution imaging is required to show directly that Dynamin-1 accumulates on microtubules of Tau-injected calyces. Furthermore, to demonstrate that the Tau-microtubule-Dynamin-1 link is specifically at the core of the deleterious effects of elevated Tau levels, it needs to be shown that actin organization is unperturbed as expected, and that the levels of key pre-synaptic proteins (e.g. endophilin) and their sub-synaptic distribution are unaffected by Tau. These issues need to be addressed experimentally.</p><p>Essential Revisions - Optional Additional Experiments or Text Redaction</p><p>The reviewers identified two additional important issues that need to be addressed. If corresponding data are available or can be generated rapidly during the revision phase, they should be included. If this turns out to be problematic, the issues should be covered in the discussion part of the paper - e.g. as an outlook (points 3 and 4) or in the context of defining the general relevance and limitations of the present study (point 4).</p><p>3. It would be very interesting to assess the effects of elevated Tau levels on other, better characterized microtubule binding proteins in the pre-synapse, e.g. Formins such as mDia, which associate with actin and microtubules and have been implicated in pre-synaptic endocytosis. Moreover, evidence from neuroendocrine cells indicates that microtubules serve as platforms to direct exo-endocytic coupling by promoting 'hopping' of Clathrin structures, so that the question arises as to whether contributions of such processes to the observed pre-synaptic rundown and endocytic blockade can be ruled out.</p><p>4. Given the prominent cortical pathology of Alzheimer's Disease, it would be very informative to assess whether the principal observation that increased levels of soluble Tau sequester Dynamin-1 on microtubules holds true for synapses other than the Calyx of Held, for example central cortical synapses.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73542.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions - Additional Experiments:</p><p>1. The PH domain-derived peptide used for the experiments documented in Figure 5 is part of a tightly folded domain (i.e. as a loop-β-fold, see PDB 2YS1). No data are presented to demonstrate that the PH domain of Dynamin-1 indeed binds to microtubules directly (or indirectly) in vitro and in vivo (or in living neurons). Indeed, it is questionable that the short PHDP5 12-mer peptide, when presented outside its sequence context within the PH domain folds into its native structure and exhibits its physiological set of interactions.</p></disp-quote><p>We performed confocal and electron microscopic imaging using purified MT and GST-tagged PH domain of dynamin 1 (GST-PH). The results strongly suggest that the dynamin 1 PH domain can directly interact with MTs (new Suppl Figure S4, explanations in the text p5, third paragraph).</p><p>As reported in cryo-EM study on dynamin assembled on lipid membrane (Konig et al., 2018 Nature), upon GTP hydrolysis the PH domain can be exposed toward membrane by a conformational change from a position tucked up into dynamin structure. Like the dynamin-lipid membrane interaction (Zhang and Hinshaw, 2001 Nat Cell Biol), dynamin-MT interaction involves periodical arrangements of dynamins on the MT surface, suggesting their helical polymerization (La et al., 2020 FASEB J). Therefore, dynamin 1 PH domain comprising the putative binding site PHDP5 can be exposed toward MT surface (p5, third paragraph).</p><disp-quote content-type="editor-comment"><p>A thorough biochemical characterization of the association of Dynamin-1 with microtubules is a prerequisite to interpret the results shown in Figure 5, which indicate a partial rescue of Tau induced endocytic defects by a rather high concentration (1 mM) of PHDP5 peptide. Moreover, additional complementary tools (e.g. expression or injection of WT vs. mutant forms of Dynamin-1 or its PH domain) should be used to assess the role of the alleged microtubule binding site in Dynamin-1 that is proposed to mediate the effects of Tau on pre-synaptic function. These issues need to be addressed experimentally.</p></disp-quote><p>We performed biochemical experiments trying to characterize binding of dynamin 1 PH domain to microtubules. Unfortunately, however, GST-PH formed large complexes (Figure S4B) and sedimented into pellet after centrifugation, therefore we were unable to separate MTs between bound and unbound forms. We then performed glutathione beads separation experiments, but it did not work since MT bound to the beads even without PH domain. We did not perform overexpression experiments of PH domain-deleted/mutated dynamin 1 since it can change dynamin 3D structure. The concentrations of PHDP5 (0.25-1.0 mM) used for intra-terminal injection is comparable to that of dynamin 1 PRD peptide (1 mM) shown to block vesicle endocytosis by intra-terminal loading at the calyx of Held (Yamashita et al., 2005 Science).</p><disp-quote content-type="editor-comment"><p>2. The link between elevated microtubule assembly and Dynamin-1 recruitment discussed in the context of Figure 4 remains loose. In the confocal images of fluorescently labeled calyces in Figure 4A, beta3-Tubulin and Dynamin-1 are shown. Is there direct evidence to show that the alleged increase in beta3-Tubulin levels is due to elevated microtubule assembly or stability elicited by microinjected tau? Confocal resolution is insufficient to differentiate Dynamin-1 located in the pre-synaptic cytoplasm from Dynamin-1 bound to microtubules. Super-resolution imaging is required to show directly that Dynamin-1 accumulates on microtubules of Tau-injected calyces.</p></disp-quote><p>Although presynaptic terminals tend to suffer from whole-cell perturbation and pipette retraction after tau loading, we managed to have obtained super-resolution imaging data showing that dynamins are colocalized with microtubules in a tau-infused presynaptic terminal (Figure S2).</p><disp-quote content-type="editor-comment"><p>Furthermore, to demonstrate that the Tau-microtubule-Dynamin-1 link is specifically at the core of the deleterious effects of elevated Tau levels, it needs to be shown that actin organization is unperturbed as expected, and that the levels of key pre-synaptic proteins (e.g. endophilin) and their sub-synaptic distribution are unaffected by Tau. These issues need to be addressed experimentally.</p></disp-quote><p>We did not perform actin imaging for the following reasons: (i) Unlike FTDP mutant tau, wild-type tau cannot bind to actin (Roger et al., 2004, quoted in our manuscript). (ii) The toxic effects of wild-type tau on vesicle endocytosis and synaptic transmission were fully rescued by microtubule-depolymerizing reagent nocodazole (Figure 3). (iii) At the calyx of Held, there is no evidence for vesicle endocytosis to be supported by the F-actin-based endocytic scaffold mechanism involving endophilin, formin or intersectin. On the contrary, F-actin depolymerization with latrunculin treatments (Eguchi et al. 2017 J Neurosci; Piriya Ananda Babu et al. 2020 J Neurosci) or genetic ablation of intersectin (Sakaba et al., 2013 PNAS) has no effect on vesicle endocytosis at the calyx of Held. Endophilin together with synaptojanin reportedly mediates ultra-fast endocytosis and SV uncoating and following acidification, but their deficiency has no effect on clathrin-mediated endocytosis (Watanabe et al., 2018), which is a dominant form of endocytosis at the calyx of Held.</p><disp-quote content-type="editor-comment"><p>Essential Revisions - Optional Additional Experiments or Text Redaction</p><p>The reviewers identified two additional important issues that need to be addressed. If corresponding data are available or can be generated rapidly during the revision phase, they should be included. If this turns out to be problematic, the issues should be covered in the discussion part of the paper - e.g. as an outlook (points 3 and 4) or in the context of defining the general relevance and limitations of the present study (point 4).</p><p>3. It would be very interesting to assess the effects of elevated Tau levels on other, better characterized microtubule binding proteins in the pre-synapse, e.g. Formins such as mDia, which associate with actin and microtubules and have been implicated in pre-synaptic endocytosis.</p></disp-quote><p>Using capacitance measurements, we have tested the effect of the formin inhibitor SMFH2 on vesicle endocytosis at the calyx of Held in slices from post-hearing mice (Figure S5A). Although SMFH2 reportedly inhibits endocytosis at the calyx of Held in slices from pre-hearing rats (P8-P12, Soykan et al, 2017, Neuron), it had no significant effect on exo-endocytosis at the calyx of Held from post-hearing mice (P13-14). Thus, association of formin with MT or F-actin cannot explain the endocytic inhibition by tau (Figure 2 and Figure 3B, explanations in p4, 4<sup>th</sup> paragraph). These new data are obtained by Satyajit Mahapatra, who is now included as a co-author in our revised manuscript.</p><disp-quote content-type="editor-comment"><p>Moreover, evidence from neuroendocrine cells indicates that microtubules serve as platforms to direct exo-endocytic coupling by promoting 'hopping' of Clathrin structures, so that the question arises as to whether contributions of such processes to the observed pre-synaptic rundown and endocytic blockade can be ruled out.</p></disp-quote><p>We could not reach the paper indicating “hopping” promoted by MTs, but if it is related to SV uncoating, its block can affect vesicle refilling with glutamate, thereby reducing the mean quantal size. However, tau had no such effect with no sign of alteration in the amplitude or frequency of quantal EPSCs (Figure S5B, explained in p4, last paragraph and p5, first paragraph).</p><disp-quote content-type="editor-comment"><p>4. Given the prominent cortical pathology of Alzheimer's Disease, it would be very informative to assess whether the principal observation that increased levels of soluble Tau sequester Dynamin-1 on microtubules holds true for synapses other than the Calyx of Held, for example central cortical synapses.</p></disp-quote><p>This is important but beyond the scope of our present slice model study. We plan to test this in our ongoing tau-propagation culture model.</p></body></sub-article></article>